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Abstract 
 
Hantaviruses (family Bunyaviridae, genus Hantavirus) are enveloped viruses 
incorporating a segmented, negative-sense RNA genome. Each hantavirus is carried by its 
specific host, either a rodent or an insectivore (shrew), in which the infection is 
asymptomatic and persistent. In humans, hantaviruses cause Hemorrhagic fever with 
renal syndrome (HFRS) in Eurasia and Hantavirus cardiopulmonary syndrome (HCPS) in 
the Americas. In Finland, Puumala virus (genus Hantavirus) is the causative agent of NE, 
a mild form of HFRS. The HFRS-type diseases are often associated with renal failure and 
proteinuria that might be mechanistically explained by infected kidney tubular cell 
degeneration in patients. Previously, it has been shown that non-pathogenic hantavirus, 
Tula virus (TULV), could cause programmed cell death, apoptosis, in Vero E6 monkey 
kidney cell cultures. This suggested that the infected kidney tubular degeneration could 
be caused directly by virus replication.  In the first paper of this thesis the molecular 
mechanisms involved in TULV-induced apoptosis was further elucidated. TULV-infected 
cells were analyzed by immunoblotting with antibodies specific for the activated, 
phosphorylated forms of extracellular signal-regulated kinases 1 and 2 (ERK1/2), which 
are known to promote cell survival. A virus replication-dependent down-regulation of 
ERK1/2, concomitantly with the induced apoptosis, was identified. In addition, this 
phenomenon was not restricted to TULV or to non-pathogenic hantaviruses in general 
since also a pathogenic hantavirus, Seoul virus, could inhibit ERK1/2 activity. However, 
TULV was clearly the strongest cell death inducer of the studied viruses, and this also 
correlated with its ability to grow more efficiently in cell culture compared to other 
hantaviruses. Interestingly TNF-α, expression of which is associated with more severe 
hantavirus-mediated disease and is found to be locally expressed in the kidneys of 
diseased individuals, markedly decreased ERK1/2 activity in hantavirus-infected cells. 
This was also seen in Puumala virus-infected cells where ERK1/2 inhibition was not 
observed solely by virus replication. In general, these data indicate that hantavirus 
infection in tubular kidney cells may have detrimental effects on cell viability, which can 
be the cause of renal failure in the course of HFRS. 
Hantaviruses consist of membrane-spanning glycoproteins Gn and Gc, RNA-dependent 
RNA polymerase (L protein) and nucleocapsid protein N, which encapsidates the viral 
genome, and thus forms the ribonucleoprotein (RNP). Interaction between the 
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cytoplasmic tails of viral glycoproteins and RNP is assumed to be the only means how 
viral genetic material is incorporated into infectious virions. In the second paper of this 
thesis, it was shown by immunoprecipitation that viral glycoproteins and RNP interact in 
the purified virions. It was further shown that peptides derived from the cytoplasmic tails 
(CTs) of both Gn and Gc could bind RNP and recombinant N protein. In the fourth paper 
the cytoplamic tail of Gn but not Gc was shown to interact with genomic RNA. This 
interaction was probably rather unspecific since binding of Gn-CT with unrelated RNA 
and even single-stranded DNA were also observed. However, since the RNP consists of 
both N protein and N protein-encapsidated genomic RNA, it is possible that the viral 
genome plays a role in packaging of RNPs into virions. On the other hand, the nucleic 
acid-binding activity of Gn may have importance in the synthesis of viral RNA. Binding 
sites of Gn-CT with N protein or nucleic acids were also determined by peptide arrays, 
and they were largely found to overlap.  
 
The Gn-CT of hantaviruses contain a conserved zinc finger (ZF) domain with an 
unknown function. Some viruses need ZFs in entry or post-entry steps of the viral life 
cycle. Cysteine residues are required for the folding of ZFs by coordinating zinc-ions, and 
alkylation of these residues can affect virus infectivity. In the third paper, it was shown 
that purified hantavirions could be inactivated by treatment with cysteine-alkylating 
reagents, especially N-ethyl maleimide. However, the effect could not be pin-pointed to 
the ZF of Gn-CT since also other viral proteins reacted with maleimides, and it was, 
therefore, impossible to exclude the possibility that other cysteines besides those that 
were essential in the formation of ZF are required for hantavirus infectivity. 
 
 Review of the literature  
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1 Review of the literature 
 
1.1 Discovery and Classification 
 
1.1.1 Discovery of hantaviruses 
 
Epidemic hemorrhagic fever that occurred among United Nation´s soldiers during the war 
between North and South Korea in 1951 initiated the search for an etiological agent of 
this disease (later called Korean hemorrhagic fever; KHF). Before the Korean War, the 
disease was already recognized in East Asia by Russian and Japanese scientists (Smadel, 
1953), and was described not as a contagious disease between humans but as a “place 
disease” designating the site (specific geographic area) where humans acquired the 
disease. It was suspected already in the 1950´s that the disease was carried by rodents. 
However, it took 25 years to finally discover the microbe responsible for KHF, and in 
1978 the hantavirus prototype Hantaan virus (referring to river Hantan at the border of 
North and South Korea) was isolated from field mouse Apodemus Agrarius (Lee et al., 
1978).  
By then a hemorrhagic fever with similar clinical symptoms had been recognized in 
Scandinavia where it was called Nephropathia Epidemica (NE). Its causative agent, 
Puumala virus, was isolated from bank voles (Myodes glareolus) in 1980 (Brummer-
Korvenkontio et al., 1980; Lahdevirta, 1971; Yanagihara et al., 1984b). These two 
diseases, KHF and NE, with distribution from Europe to Far East were collectively called 
as hemorrhagic fever with renal syndrome (HFRS), and the causative agents were 
specified as a new genus, named Hantavirus, in the virus family Bunyaviridae of 
enveloped RNA viruses (Schmaljohn et al., 1985; Traub & Wisseman, 1978).  
Thereafter it did not take long to detect a hantavirus-caused disease also in Northern 
America. However, the newly-discovered hantavirus did not cause HFRS as the 
hantaviruses of Eurasia, but an acute respiratory illness with very high mortality (Hughes 
et al., 1993; Nichol et al., 1993). This disease was originally named hantavirus pulmonary 
syndrome (HPS) and is today called hantavirus cardiopulmonary syndrome (HCPS) due 
to the involvement of cardiac depression. The prototype HCPS-causing hantavirus (Sin 
Nombre virus; SNV) is carried by a deer mouse (Peromyscus maniculatus) (Childs et al., 
1994). This was, however, not the first time a hantavirus was discovered in the Americas 
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since in 1983 Prospect Hill hantavirus (PHV) was identified in meadow voles (Microtus 
pennsylvanicus) (Yanagihara et al., 1984a), but this virus has never been associated with 
any disease, and is, therefore, used as the primary model for a non-pathogenic hantavirus. 
 
Currently, the hantavirus genus includes more than 30 species of which only a few are 
associated with HFRS and others either with HCPS or not associated with any disease. 
Each hantavirus species is maintained in nature in its own specific animal reservoir, 
rodents. Hantaviruses do not cause any clearly identifiable symptoms in their carrier hosts 
and infection of secondary host (e.g. human), which probably takes place through 
aerosols from rodent excreta, is thought to be a dead end for the virus (spillover 
infection). Recently, many shrew-borne hantaviruses has been discovered (Jonsson et al., 
2010). However, shrew-borne hantaviruses are genetically distinct from rodent-borne 
hantaviruses and it is not known whether they cause a disease in humans (Kang et al., 
2009). 
 
1.1.2 Classification of hantaviruses  
 
Based on genetic and antigenic determinants hantaviruses form a single genus in the 
family Bunyaviridae (Schmaljohn et al., 1985), which in addition to the Hantavirus genus 
include Tospovirus, Phlebovirus, Nairovirus and Orthobunyavirus genuses (Elliott et al., 
2000). Viruses in the Bunyaviridae family possess similar morphological and genetic 
characteristics with each other including enveloped spherical virus particles and negative-
sense, single-stranded RNA genome, which is divided into three segments of different 
sizes. The classification of different genuses among bunyaviruses is based on variation in 
their genomic 3′-terminal sequences, which are conserved within genus. Hantaviruses 
possess a 3′-terminal “AUCAUCAUCUG” sequence in each of their genome segments 
(Schmaljohn et al., 1985). Based on the segmented genome, bunyaviruses can be 
classified with Orthomyxoviridae (including influenzaviruses A, B and C) and 
Arenaviridae families to distinguish them from non-segmented negative-sense RNA 
viruses (Order Mononegavirales). A typical feature of the negative-sense, segmented 
ssRNA viruses (NSRV) is “cap-snatch” mechanism for mRNA synthesis. Virus 
“classification” is also possible by analyzing the transmitting agent. Virus members in 
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Hantavirus genus are carried by rodents or shrews while viruses in the other genuses 
within the family Bunyaviridae are arthropod-borne.  
 
1.2 Cell biology of hantaviruses 
 
1.2.1 Virion 
 
Hantaviruses are enveloped RNA viruses in the family Bunyaviridae. They have a 
negative-sense genome divided into small (S), middle (M) and large (L) segments, which 
encode for a nucleocapsid protein (N; approx. 430 amino acids [aa]), envelope 
glycoprotein precursor (approx. 1180 aa) and RNA-dependent RNA polymerase (L 
protein; approx. 2530 aa), respectively (Plyusnin et al., 1996). The N protein encapsidates 
the genomic RNA and forms three differently-sized ribonucleoproteins (RNPs), which are 
packaged inside the viral envelope (Fig. 1). The L protein is generally thought to be 
associated with the RNPs and is required for the replication and transcription of the virus 
in infected cells. The glycoprotein precursor is cleaved to Gn (approx. 630 aa N-terminal 
part of the precursor) and Gc (approx. 540 aa C-terminal part of the precursor) 
glycoproteins by a signal peptidase complex in the cells prior to virus assembly (Lober et 
al., 2001). The Gn and Gc form a complex on the outer surface of the virion. Both 
glycoproteins span the viral membrane in such a way that their C-terminal parts 
(cytoplasmic tails [CT]) are towards the intraviral space (or cytoplasmic side) while the 
other parts of the proteins are in contact with the outer environment (ectodomains). The 
CTs of Gn and Gc are remarkably different in size probably reflecting their importance in 
various processes during the viral life cycle (Gn 110 aa vs. Gc 10 aa). The Gn-CT has a 
tandem CCHC-type zinc finger domain (ZF) of unknown function (Estrada et al., 2009) 
and a conserved YxxL endocytosis motif. The Gn-CT ends in a membrane-spanning 
signal sequence for Gc but it is uncertain whether the signal sequence is actually 
incorporated in the virions and whether it continues to be embedded in the membrane 
after Gc cleavage.  
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Figure 1. Virion structure. The hantaviral envelope consists of glycoproteins Gn and Gc. The genomic 
RNAs are encapsidated by nucleocapsid protein to form the ribonucleoprotein (RNP) complexes that are 
packaged inside the viral envelope. The genome is tripartite giving rise to three differently-sized RNPs. The 
cytoplasmic tail (CT) of Gn is exposed to interior of the virion and harbours a zinc finger (ZF) domain. It is 
unknown whether the C-terminal part of Gn-CT, containing the signal sequence for Gc, is actually 
incorporated into virions and whether it spans the viral envelope. 
 
The structural organization of glycoproteins in the hantavirus particles is unique (Battisti 
et al., 2010; Hepojoki et al., 2010; Huiskonen et al., 2010). By analyzing the interaction 
of Gn and Gc (Hepojoki et al., 2010) it was shown recently that TULV Gn preferably 
forms homo-oligomers (dimers or tetramers) and Gc homodimers in the virion rather than 
heterodimers as was generally believed.  The formation of heterodimers of Gn and Gc in 
infected cells has been shown for HTNV (Antic et al., 1992) but it is possible that 
glycoproteins rearrange to higher order complexes prior or during virus assembly. By 
chemical cross-linking of TULV particles it was also suggested that the homo-oligomeric 
Gn and Gc interact to form hetero-oligomeric complexes on the surface of TULV (spikes) 
and that Gn is more distal than Gc from the viral envelope due to its higher susceptibility 
to the applied cross-linking (Hepojoki et al., 2010). This has led to a model of 
glycoprotein organization on the surface of hantavirus particles where Gn glycoproteins 
form tetrameric complexes, which are interconnected to each other by dimers of Gc 
(depicted in Fig. 1). The existence of this type of glycoprotein organization in 
hantavirions was confirmed by electron cryo-tomography of TULV (Huiskonen et al., 
2010) and HTNV (Battisti et al., 2010) particles, which indicated the presence of square-
shaped spike complexes with four-fold symmetry at the virion surface and formation of 
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tetrameric Gn and/or Gc complexes. The grid–like four-fold symmetry of hantavirion 
surfaces is unique among enveloped viruses (Huiskonen & Butcher, 2007) and unlikely to 
be a general phenomenon among bunyaviruses since members of the Phlebovirus genus 
show pentagon- or hexagon-shaped glycoprotein organization, which is probably formed 
by Gn-Gc heterodimers (Huiskonen et al., 2009). 
 
1.2.2 Entry 
 
1.2.2.1 Receptors 
Hantaviruses replicate primarily in the endothelium of infected patients, and endothelial 
cell cultures are susceptible to hantavirus infection in vitro (Schmaljohn & Nichol, 2007). 
Endothelial cells together with Vero E6 cells are the most widely employed models for 
hantavirus infectivity and cell biological studies. It is well established that integrins 
permit hantavirus infection in these cells probably through a direct interaction with the 
ectodomains of the viral envelope glycoproteins. Integrins are cell surface proteins 
playing a major part in cell adhesion to the extracellular matrix and, therefore, affect 
many aspects of cell and tissue functions including vascular haemostasis (Hynes, 2002). 
The initial findings that these proteins are hantavirus receptors came from cell infection 
studies in which infection of HCPS- or HFRS-causing hantaviruses was blocked by 
antibodies against integrin αVβ3 or its ligand, vitronectin. In contrast, PHV, which is 
regarded as a non-pathogenic hantavirus, was blocked by antibodies against integrin α5β1 
or its ligand fibronectin (Gavrilovskaya et al., 1998; Gavrilovskaya et al., 1999). The 
initial idea that pathogenic and non-pathogenic hantaviruses differ in their receptor usage 
was further supported by the fact that TULV, a rather non-pathogenic old-world 
hantavirus, was found to be unable to block endothelial cell migration on αVβ3 integrins in 
contrast to pathogenic hantaviruses (Gavrilovskaya et al., 2002). Typically αVβ3 recognize 
an arginine-glycine-aspartic acid (RGD) peptide motif present on their binding partners 
but the infectivity of pathogenic hantavirus is shown to be RGD-independent 
(Gavrilovskaya et al., 1998; Hall et al., 2007) and instead is mapped to plexin-
semaphorin-integrin (PSI) domain present on inactive integrins (Matthys et al., 2010; 
Raymond et al., 2005). These findings suggested that pathogenic hantaviruses are capable 
of regulating vascular permeability, which is responsible for interstitial hemorrhage and 
development of shock in hantavirus-infected patients, through altering activity state of 
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integrin. The use of integrin β3 as hantavirus receptor in cell cultures was further 
recognized by using peptides and peptidomimetics that competed for virus-integrin 
binding (Hall et al., 2007; Hall et al., 2010; Larson et al., 2005). Hantaviral inhibitory 
molecules were more effective against SNV than PHV emphasizing the link between 
integrin recognition and pathogenicity at least in the case of new-world hantaviruses. 
Platelets express another type of integrin, αIIbβ3, on their surface through which 
monolayers of pathogenic hantavirus-infected, but not TULV-infected, endothelial cells 
have been shown to recruit platelets (Gavrilovskaya et al., 2010). This is an interesting 
mechanism, which could explain the commonly observed platelet loss 
(thrombocytopenia; Table 1) in the bloodstream of infected patients (see 1.3.1).      
The above-mentioned studies show hantavirus-integrin interaction in cell culture models 
but data indicating the importance of integrins for hantavirus infectivity in vivo are 
limited. Antibodies that recognize and block integrin αVβ3 have been shown to reduce 
viral loads in SNV-infected mice (Medina et al., 2007) and prolong survival of HTNV-
infected newborn murine pups (Song et al., 2005). The latter study suggested that 
antagonist to αVβ3, action of which is analogous to RGD, was shown have a positive 
effect on survival, casting a doubt over the specificity of this study. The lack of 
appropriate animal model in hantavirus research has complicated the investigations on the 
role of integrins as in vivo receptors for these viruses. 
The ability of integrin-specific antibodies or peptides in blocking of hantavirus infectivity 
in Vero E6 cell cultures is not highly robust (commonly an inhibition of 50-80% was 
obtained) and the existence of another cellular receptor to hantaviruses could not be ruled 
out by integrin-focused studies (Gavrilovskaya et al., 1998; Gavrilovskaya et al., 1999; 
Hall et al., 2007). Therefore, it was not surprising that another receptor for hantaviruses in 
cultured cells was found, namely decay accelerating factor (DAF)/CD55 (Krautkramer & 
Zeier, 2008). This cell membrane protein plays a part in inhibiting the complement 
system of the innate immunity. It acts in concert with integrin αVβ3 to facilitate entry of 
HFRS-causing hantaviruses into cultured cells but can also act as the sole cellular 
receptor for hantaviruses in the absence of integrin αVβ3 (Buranda et al., 2010). Another 
cellular protein of the complement system, C1qR/p32, has also been postulated to be 
involved as a co-receptor in hantavirus entry in Vero E6 cells (Choi et al., 2008) but its 
direct role in virus entry remains unclear. 
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1.2.2.2 Penetration 
After binding to a cell surface receptor, enveloped viruses need to fuse with cell 
membranes in order to penetrate and release their genetic material into the host cell 
cytoplasm. The fusion can be accomplished directly with the plasma membrane or more 
commonly with inner membranes of the cell after endocytosis. Fusion with intracellular 
organelles as opposed to plasma membrane carries many advantages for viruses including 
exploitation of the endocytic transport machinery to reach the inner parts of the cell and 
utilization of the pH gradient in the endocytic pathway to activate fusion at specific 
subcellular locations. It is also beneficial that viral proteins are not exposed to the outer 
environment of the cell after fusion that would otherwise induce antiviral responses. The 
endocytosis pathways can be roughly divided into clathrin-dependent, clathrin-
independent, caveosomal and macropinocytosis pathways. Clathrin-dependent pathway 
and low-pH induced fusion either at early endosomes (pH 6.0-6.5) or late endosomes (pH 
5.5-6.0) are most often used by viruses (Marsh & Helenius, 2006). Clathrin-dependent 
pathway is also exploited by hantaviruses (Jin et al., 2002), and fusion is thought to occur 
at early endosome (Fig. 2) because hantavirus-infected cells fuse and form syncytia when 
exposed to pH 6.2-6.3 (Arikawa et al., 1985; McCaughey et al., 1999). 
Fusion between viral and cellular membranes requires activation of viral fusion 
protein(s). These are viral surface proteins anchored on the viral envelope through a 
transmembrane domain and harboring a hydrophobic fusion peptide buried from the outer 
milieu in the native state of the virion. Fusion proteins can be divided into class 1 or 2 
depending on the mechanism of how they exert the fusion process; this is accomplished 
either by receptor binding, exposure to low pH or both (Kielian & Rey, 2006). The 
hantaviral fusion protein (and bunyaviral in general) has been assumed to be the Gc 
envelope glycoprotein by computational modeling (Garry & Garry, 2004; Tischler et al., 
2005) which was also used to predict the amino acid residues responsible for fusion 
(fusion peptide). Experimental evidence for this has been lacking until lately when it was 
shown that TULV Gc is subjected to conformational changes upon exposure to low pH at 
6.2 (Hepojoki et al., 2010) and that mutations in the putative fusion peptide of Gc 
affected the fusion and entry of hantavirus glycoprotein pseudotyped-lentiviral particles 
(Cifuentes-Munoz et al., 2011).   
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Figure 2. Life cycle of hantaviruses. Virus enters the cell by clathrin-mediated endocytic pathway, and fuses 
with the early endosomal membrane (EE) to release its genetic material into the cytoplasm. Replication 
complexes (RC) are formed close to endoplasmic reticulum (ER) and Golgi complex (GC). Assembled 
virions bud to the lumen of the Golgi. Viruses travel through the GC and enter recycling endosome (RE) 
from where they are released by exocytosis. PM = Plasma membrane, LE = late endosome. 
 
The conformational changes in the viral fusion proteins required prior to fusion with 
cellular membranes may involve rearrangements of disulfide bridges as has been shown 
for a number of different virus families including class 1 and 2 fusion proteins (Sanders, 
2000). These so-called thiol/disulfide exchange reactions are catalyzed either by a cellular 
disulfide isomerase (PDI) expressed on the surface of the cell or by a virally encoded PDI 
activity. The PDI activity is exerted through a CxxC motif (Freedman et al., 1994). 
Intriguingly, hantaviral glycoprotein Gn and Gc ectodomains are rich in cysteine residues 
and they possess numerous CxxC motifs. However, the functions of CxxC motifs in 
virus-cell membrane fusion have not been elucidated. 
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1.2.3 RNA synthesis 
 
1.2.3.1 Overview of the replication strategy of NSRV 
After penetration into host cells, viral proteins are synthesized and genomes are replicated 
in order to produce progeny viruses. To achieve this, the RNPs need to be transported to 
the site of replication. While this step is poorly investigated for hantaviruses or other 
genera in the family Bunyaviridae, the replication strategy of these viruses is better 
understood. Negative-stranded segmented RNA viruses (NSRV) need their genome to be 
transcribed into positive-sense RNA (mRNA) to serve as template for viral protein 
synthesis on cellular ribosomes. Unlike positive-sense RNA viruses, which can use the 
genomic RNA directly as mRNA for protein synthesis, negative-sense RNA viruses have 
virus-encoded transcriptase associated with the viral ribonucleoprotein (RNP). The 
NSRVs harbor open reading frames on each individual RNA segments (on S, M and L 
segments in the case of bunyaviruses) whereas the genes of non-segmented viruses are 
transcribed from common RNA template. The reason for genome segmentation is unclear 
but could involve increased transcriptional regulation of individual viral genes with 
promoters with different transcriptional efficiency. On the other hand, there is a 
requirement to enclose at least one copy of each of the segments into the progeny viruses 
instead of just one RNA molecule as is the case for non-segmented viruses. In addition to 
mRNAs, negative-sense RNA viruses need to generate complementary RNA (cRNA) 
from the viral genomic strand, which then acts as a template for the synthesis of viral 
genomic RNA (vRNA). Like vRNA, cRNA is also encapsidated by the nucleocapsid and 
therefore active viral (N) protein synthesis is thought to be prerequisite for the replication 
process (Kolakofsky & Hacker, 1991; Schmaljohn & Nichol, 2007). A model suggesting 
a switch from transcription to replication as depicted in Fig. 3 is challenged with studies 
made on influenza (family Orthomyxoviridae) which suggested that the production of 
mRNA and cRNA occur concomitantly but cRNA is stabilized only by newly synthesized 
polymerase and nucleocapsid (Vreede et al., 2004; Vreede & Brownlee, 2007). 
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Figure 3. Outline of hantavirus replication and progeny virus production. Following the entry of the viral 
RNP into host cell cytoplasm, viral negative sense (-) RNAs (vRNA) is transcribed by the transcriptase 
activity of RNP-associated L protein into mRNAs, which are subsequently translated by host cell ribosomes 
to viral proteins. The newly-synthesized N protein is necessary for the replication of vRNA, in which the 
viral complementary RNA (cRNA) acts as template for the synthesis of more (-) vRNA. The cRNA and 
vRNA production is dependent on the replicase activity of L protein. The replicated vRNA is finally 
assembled together with L, N, Gn and Gc to form progeny virions. The protein coding sequences (open 
reading frames; ORFs) of the RNA are marked in black and non-translated regions of the RNA in white. 
The sizes of S, M and L segments together with their ORFs reflect their comparable size in nature.   
    
1.2.3.2 The RNA synthesis mechanism of hantaviruses 
The RNA synthesis mechanism in the case of hantaviruses is relatively poorly studied in 
comparison to other genera of Bunyaviridae mainly due to a lack of a feasible reverse 
genetics system. However, the mechanisms of RNA synthesis among bunyaviruses (and 
among other NSRV) are considered to be conserved and, therefore, studies made on other 
bunyaviruses are likely to be applicable for hantaviruses. Reverse genetics systems based 
on minigenomes that are active in transcription and replication have been utilized with 
orthobunyaviruses and phleboviruses. The successive replication of minigenomes is 
preliminary stage in the rescue of infectious viral clones solely from transfected plasmids 
encoding viral proteins and RNA (Bouloy & Flick, 2009). It is well established that 3′-
terminal non-translated (NTR) sequences (Fig. 3) of the viral genomic RNAs act as 
promoters for the initiation of transcription. As mentioned before, these 3′-terminal 
nucleotides have perfect complementary to 5′-termini of the corresponding genomic RNA 
molecule (Fig. 4a) and base pair to form panhandle structures resulting in circularized 
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RNPs in the virion (Raju & Kolakofsky, 1989) and possibly in infected cells. The 
complementarity of the 5′-terminus is also important for the efficiency of the 3′-end 
transcriptional promoter as shown for orthobunyavirus prototype Bunyamwera virus 
(BUNV) (Barr & Wertz, 2004; Kohl et al., 2004) and Rift valley fever virus (RVFV) and 
Uukuniemi virus (UUKV) of the genus Phlebovirus (Flick et al., 2004; Flick et al., 2002; 
Gauliard et al., 2006).  
The S segment-derived mRNA has been shown to be the most abundant species of the 
three mRNAs in SNV- (Hutchinson et al., 1996) and RVFV-infected cells (Gauliard et 
al., 2006). In the case of purified tomato spotted wilt virus (TSWV; genus Tospovirus) 
the S segment possessed the strongest transcriptional activity in vitro (van Knippenberg et 
al., 2002), which may reflect the requirement for newly synthesized N protein early in the 
replicative phase of the genome (Fig. 3). On the other hand, when analyzed in the context 
of reverse genetics systems, the strongest promoters were detected in M segment of 
BUNV and UUKV and L segment of RVFV (Barr et al., 2003; Flick et al., 2004; 
Gauliard et al., 2006; Kohl et al., 2004). There are indications that ongoing protein 
synthesis is compulsory for completion of transcription since premature termination of 
RNA transcripts in the absence of ribosomes in vitro or in the presence of protein 
synthesis inhibitors in vivo have been detected (Bellocq et al., 1987; Raju & Kolakofsky; 
1987; Vialat & Bouloy, 1992).  
A specific “corkscrew” structure has been shown to be required for the promoter activity 
of Orthomyxoviridae viruses (Flick & Hobom, 1999; Leahy et al., 1998; Leahy et al., 
2001). Interestingly, the genomes of all viruses in the family Bunyaviridae with the 
exception of phlebovirus genomes can fold into this structure suggesting an analogous 
transcription initiation mechanism within these viruses (Fig. 4b) (Flick et al., 2002). All 
NSRVs use a process called “cap snatching” for the initiation of mRNA transcription. 
This was first described for influenza (Bouloy et al., 1978), and it revealed the use of host 
cell mRNA-derived capped primers for viral mRNA transcription by the viral 
polymerase. “Cap snatching” requires a virally encoded endonuclease activity, which 
produces around 10-20 oligonucleotides long capped primers from host cell mRNAs 
(Duijsings et al., 2001; Jin & Elliott, 1993; Patterson et al., 1984; van Knippenberg et al., 
2005; Vialat & Bouloy, 1992).  In contrast to transcription, replication of NSRVs initiates 
de novo by a complementary nucleotide triphosphate. 
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Prime and re-align mechanism for the initiation of the synthesis of genomic RNA and 
mRNA has been suggested for hantaviruses (Garcin et al., 1995). This is based on the 
observations that genomic 3′-ends of hanta- and nairoviruses consist of AMP, which 
requires replication to initiate with UTP on the opposite strand and result in a tri-
phoshorylated U as the terminal 5′-end nucleotide of the newly synthesized RNA. 
However, pyrimidines (U and C) are not regarded to be efficiently utilized for initiation 
of RNA synthesis. The prime and re-align mechanism, therefore, gives an explanation of 
how hantaviruses overcome this obstacle by initiating replication with GTP (Garcin et al., 
1995). It also explains why the synthesized mRNAs contain viral sequences upstream of 
the genome-templated sequence. It has also been suggested that the viral endonuclease 
specifically cleaves the host cell derived-primers after GMP and is required for trimming 
of the cRNA and vRNA 5′-termini to yield monophosphorylated U at the end. The 
existence of monophosphorylated hantaviral genomes were shown by (Garcin et al., 
1995) for HTNV and recently for a subset of old-world hantaviruses (Wang et al., 2011) 
corroborating the postulated model of prime and re-align for RNA synthesis initiation in 
hantaviruses (Fig. 4c).  
 
 
Figure 4. Initiation of transciption and replication by hantaviruses. (A) The consensus sequence of the 
complementary termini of the negative-sense hantaviral genomes forming a “panhandle” structure. (B) The 
predicted “corkscrew” structure in the panhandle with possible role in initiation of transcription (Flick et 
al., 2002). (C) The prime and re-align mechanism as suggested for hantaviruses as the initiation mechanism 
of replication and transcription (Garcin et al., 1995). Nucleotide triphosphate is indicated by ppp and 
monophoshate by p. The cap structure in the transcriptional primer is indicated by 7mGpppN… (N refers to 
any nucleotide residue). 
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Based on the reverse genetics systems developed for different genera of bunyaviruses it is 
clear that the expression of both L and N proteins is both essential and sufficient for viral 
RNA synthesis (Bouloy & Flick, 2009; Dunn et al., 1995).  
 
1.2.3.3 L protein  
Despite being the largest protein encoded by hantaviruses (approximately 2500 aa) or 
bunyaviruses in general, the L protein is probably the least-studied. The fact that L 
protein is expressed in very low amounts especially in virions but also in infected cells 
forms the major obstacle for elucidating its functions. Since there is high level of 
conservation between bunyaviral RNA-dependent polymerases, it is possible to draw 
conclusions of the functions of hantaviral L protein from studies made with other viruses. 
It is well known through sequence conservation that the polymerase activity of 
bunyavirus polymerases is defined by six motifs named pre-motif A, A, B, C, D and E 
(Muller et al., 1994; Poch et al., 1989) that are located in the central part of the L protein 
(approximately 900-1200 aa) and form a three-dimensional structure denoted palm, finger 
and thumb (Muller et al., 1994).  
La Crosse orthobunyavirus was used as the model to demonstrate that the N-terminal part 
(1-180 aa) of the protein harbors a viral endonuclease activity involved in the initiation of 
mRNA transcription during the cap snatching process (Reguera et al., 2010). This domain 
is similar to the one found in the N-terminus of lassaviral (family Arenaviridae) L protein 
(Lelke et al., 2010; Morin et al., 2010) where it is shown to be dispensable for replicase 
activity (Lelke et al., 2010). There is also a level of conservation between N-terminus of 
La Crosse L and the orthomyxovirus polymerase complex subunit PA, which is the 
subunit shown to be responsible for endonuclease activity in the case of influenza (Dias et 
al., 2009). The orthomyxoviruses differ from bunya- and arenaviruses in the sense that 
their polymerase complexes are translocated to the nucleus of infected cells and are 
divided into three subunits: PA, PB1 and of PB2 (Boivin et al., 2010). Yet, as expected of 
the similar replication mechanism employed by all NSRVs (Fig. 3), bunya- and 
arenavirus L proteins should harbor the same functions that in the case of 
orthomyxoviruses are divided into different subunits. The middle part subunit PB1 
harbors the polymerase activity and PB2 a cap-binding activity required for cap snatching 
(Guilligay et al., 2008). Interestingly, given the high degree of conservation among the 
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endonuclease and polymerase domains of these viruses, the bunyaviral L-protein does not 
express a clearly distinguishable cap-binding domain in its C-terminal part as seen for e.g. 
influenza by sequence prediction (Reguera et al., 2010), and there is even evidence, 
which suggests that this function is passed on to N protein of bunyaviruses (Mir et al., 
2010). A recent model developed for influenza virus suggests that the transcription of 
vRNA to mRNA can initiate and proceed only by a RNP-resident polymerase complex 
(i.e in cis) in contrast to replication where a soluble polymerase complex (in addition to 
nucleocapsid) is needed for RNA synthesis (i.e. in trans) (Jorba et al., 2009; Vreede et 
al., 2004). 
 
1.2.3.4 N protein 
Hantaviruses and nairoviruses differ from other bunyaviruses in that their N protein is 
much larger (50 kDa vs. 25-30 kDa). The main function of the N protein is to encapsidate 
vRNA (and cRNA) but N protein is likely to possess other functions as well since it is the 
most abundant protein of bunyaviruses (Elliott et al., 2000).  Hantaviral N protein binds 
RNA in a non-specific fashion (Gott et al., 1993), but it has higher affinity towards the 
NCRs of vRNA, especially the 5′-end NCR (Severson et al., 1999; Severson et al., 2001). 
The 5′-end of vRNA and cRNA may, therefore, act as an encapsidation signal. A 
similarly-located encapsidation signal has also been reported for BUNV of 
Orthobunyavirus genus (Osborne & Elliott, 2000). It is unclear why mRNA, which also 
contains this putative encapsidation signal, is not encapsidated by N protein. It has been 
reported that complete transcription requires ongoing protein synthesis (Bellocq et al., 
1987), and it is possible that the cellular ribosomal translation apparatus outcompetes N-
mediated encapsidation in the case of the capped mRNA. 
N protein of hantaviruses readily forms oligomers (Alminaite et al., 2006; Alminaite et 
al., 2008; Kaukinen et al., 2005), and it has been reported that N binds the panhandle 
terminal structure of the viral RNA with higher affinity in trimeric vs. monomeric or 
dimeric form (Fig. 4a) (Mir & Panganiban, 2004).  The N protein also exhibits RNA 
chaperone activity (Mir & Panganiban, 2006a; Mir & Panganiban, 2006b). This has also 
been demonstrated for influenza nucleoprotein (Baudin et al., 1994) and can, therefore, be 
shared by all nucleocapsid proteins. The RNA chaperone activity may either aid in the 
formation of terminal panhandles of vRNAs by melting RNA secondary structures or 
 Review of the literature  
25 
 
unwind the pre-formed panhandle structures. N protein may, thus, act in transcription 
initiation together with L protein using 3′-terminus of vRNA as template. One striking 
feature of hantaviral N protein is its ability to recognize mRNA caps (Mir & Panganiban, 
2008; Mir et al., 2008; Mir et al., 2010), which is commonly thought to be exerted by the 
polymerase and which is also shown for influenza PB2 (Guilligay et al., 2008). 
Hantaviral N protein localizes to cytoplasmic processing bodies (P bodies), to which 
cellular mRNAs are being sequestered (Mir et al., 2008), and from which it may “steal” 
capped mRNAs to be used as primers for transcription. In addition, N protein augments 
translation of viral mRNA (and non-viral to lesser extent) by binding to capped mRNA 
(to the actual cap and the 5′-end triplet sequence complementary to vRNA 3′-end 
transcriptional promoter) and ribosomal protein S19 (RPS19) (Cheng et al., 2011; Haque 
& Mir, 2010; Mir & Panganiban, 2010). In all, hantaviral N protein seems to be a very 
complex protein and have a variety of functions that promote the transcription process of 
vRNA. The N proteins of other bunyaviruses are unlikely to be any simpler although 
many of them are smaller in size. This is recently supported by the finding that mutations 
in BUNV N protein differentially regulate transcription and replication of 
orthobunyaviruses (Walter et al., 2011). 
 
1.2.4 Progeny virus formation 
 
1.2.4.1 Budding 
Infection by enveloped viruses often results in rearrangement of host cell membranes that 
provides a membranous platform or microenvironment for viral replication (Mackenzie, 
2005). This is possibly the way to couple the synthesis of vRNA to the budding of viruses 
into the lumen of intracellular membranes. In the case of hantaviruses not much is known 
about the actual replication sites of the virus. However, budding of all family 
Bunyaviridae viruses is thought to take place in the Golgi complex (GC) (Elliott et al., 
2000) and for the bunyavirus prototype BUNV it is demonstrated in more detail that the 
virus exploits GC membranes to mechanistically combine viral replication and budding of 
the virus. BUNV-infection of host cells results in the formation of membraneous tubular 
structures, which are elongated inside Golgi stacks and are open towards the cytoplasm. 
The tubular structures harbor the RNA synthesis machinery of the virus, and RNPs 
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formed in the tubes associate with the Gn and Gc glycoproteins at nearby GC membranes 
before assembly and budding of the progeny virus. After budding, the virion is still 
immature but structural maturation takes place along virus egress from the cells through 
exocytosis (Fig. 2) (Fontana et al., 2008; Novoa et al., 2005; Salanueva et al., 2003). 
There is evidence suggesting that hantaviruses also bud into GC. This is because 
glycoproteins predominantly localize to GC membranes. In addition, N and L proteins of 
hantaviruses have been shown to be GC-associated peripheral membrane proteins when 
expressed individually (Kukkonen et al., 2004; Ravkov & Compans, 2001). The 
glycoproteins Gn and Gc are synthesized from a common M segment-encoded ORF and 
are cleaved co-translationally into individual proteins (Lober et al., 2001). However, 
interaction of the two glycoproteins is needed for their transport to GC whereas when 
expressed individually they reside in the ER (Deyde et al., 2005; Ruusala et al., 1992; Shi 
& Elliott, 2002; Spiropoulou et al., 2003). As their name implies Gn and Gc 
glycoproteins are glycosylated proteins. Glycosylation takes place via N-linkage by high 
mannose-type oligosaccharides. The presence of only this type of sugars indicates that 
hantaviral glycoproteins are being transported not further than cis-Golgi, which suggests 
that cis-Golgi is the budding site for the virus (Shi & Elliott, 2004). There are five 
glycosylation sites in Gn and one in Gc. In the case of Gn, glycosylation sites play the 
major role in the correct folding and transport to GC. Like other bunyaviruses, 
hantaviruses are believed to exit the cells through exocytosis. There is only one study 
showing that recycling endosome is required for hantavirus egress from infected cells 
(Rowe et al., 2008) but the secretory pathway is not well defined for any member of the 
Bunyaviridae family. Interestingly, there are reports that two new-world hantaviruses, 
BCCV and SNV, bud from the plasma membrane (Goldsmith et al., 1995; Ravkov et al., 
1997). In addition, SNV glycoproteins individually localize to plasma membrane and to 
late endosomes or lysosomes at least when over-expressed (Spiropoulou et al., 2003). If 
budding from plasma membrane is a unique phenomenon of new-world hantaviruses or in 
some particular circumstances a common feature of all hantaviruses, remains to be 
determined.  
The signal that initiates the budding event of bunyaviruses is unknown. Budding of 
membraneous negative-sense RNA viruses commonly involves a viral matrix protein 
which function, in addition to facilitating budding, is to act as a bridge between the CTs 
of the surface glycoproteins and the viral core. However, in contrast to other members of 
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NSRV, bunyaviruses do not encode a matrix protein, which exerts this function. It is, 
therefore, assumed that the CTs of Gn and/or Gc proteins possess this activity and indeed 
there is evidence for this. The development of infectious virus like particle (VLP) 
generation systems for BUNV and UUKV where transfection of plasmids encoding for all 
viral structural proteins (Gn, Gc, N and L) together with plasmids producing either full-
length or minigenomes are transiently expressed in cells (Lowen et al., 2004; Overby et 
al., 2006) has proved to be useful in elucidating the roles of different proteins in virus 
release. Firstly, mutagenesis of CTs of bunyavirus prototype BUNV suggested that both 
Gn- and Gc-CTs are required for VLP release (Shi et al., 2007). Secondly, studies with 
UUKV lead to identification of dileucine motif (Fig. 5) responsible for budding of VLPs. 
Mutation of this motif to alanines abolished budding of UUKV VLPs into GC while still 
enabling proper localization of glycoproteins on GC membranes (Overby et al., 2007b). 
Many viral matrix proteins contain late domains, which are typically four residues long 
amino acid stretches essential for virus budding (consensus sequences e.g. PT/SAP and 
YPxL). These motifs function to hijack the cellular budding machinery normally used by 
the host cell for the biogenesis of multivesicular bodies (Chen & Lamb, 2008). 
Interestingly some late domains resemble the canonical endocytosis motif Yxxθ (where θ 
is any hydrophobic amino acid) (Sorkin, 2004), which is fully conserved in Gn-CT of 
hantaviruses and also in CTs of some other bunyaviruses (Fig. 5, marked as green). 
Moreover, dileucine motif necessary for budding of UUKV is generally known to act as 
endocytosis signal (Sorkin, 2004). The putative bunyaviral endocytosis motifs, for which 
the actual functions in endocytosis have not been determined, may act similarly to late 
domains of matrix proteins and be responsible for budding. It was reported that the YxxL 
motif in hantaviruses is part of an immunoreceptor tyrosine-based activation motif 
(ITAM) consisting of tandem YxxL/I motifs (Geimonen et al., 2003b). However, the 
second C-terminally located YxxL motif identified in the study was only conserved 
among viruses of the new-world and by prediction it locates to a transmembrane domain 
(part of the signal sequence for Gc) indicating that this putative motif is unlikely to have 
any biological function in vivo. Instead, it is likely that the N-terminally located, fully 
conserved YxxL motifs possess a function in intracellular trafficking of hantaviruses.    
Different bunyavirus genera are unlikely to share the same mechanism for budding since 
the expression of UUKV and RVFV (both are phleboviruses) glycoproteins in the 
absence of N or L proteins allowed the generation of VLPs (Overby et al., 2006; Piper et 
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al., 2011) which was not the case for e.g. hantaviruses. For hantaviruses the formation of 
VLPs require simultaneous expression of M and S segments indicating that N protein in 
addition to glycoproteins is necessary for budding to occur (Betenbaugh et al., 1995). The 
developed VLP generation systems for hantaviruses that would greatly ease studies 
concerning the molecular mechanisms of progeny virus formation (Flick et al., 2003) are 
not used to a large extent probably because of the difficulties in obtaining high enough 
virus titers.  
 
Figure 5. Alignment of cytoplasmic tails (CTs) of bunyaviral glycoproteins. Amino acids predicted to 
coordinate zinc-ions in a zinc finger fold are shown in red. A possible late-domain in hantaviral Gn-CT is 
shown in green. TULV = Tula virus, PHV = Prospect Hill virus, PUUV = Puumala virus, SNV = Sin 
nombre virus, ANDV = Andes virus, HTNV = Hantaan virus, SEOV = Seoul virus, SHV = Snowshoe Hare 
virus, LCV = La Crosse virus, BUNV = Bunyamwera virus, TSWV = Tomato spotted wilt virus, SVNV = 
Soybean Vein necrosis virus, MYSV = Melon yellow spot virus, PTV = Punta Toro virus, RVFV = Rift 
velly fever virus, SFSV = Sandfly fever Sicilian virus, UUKV = Uukuniemi virus, NSDV = Nairobi sheep 
disease virus, DUGV = Dugbe virus, CCHFV = Crimean-Congo hemorrhagic fever virus.   
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1.2.4.2 Assembly  
In order to produce infectious viruses all NSRVs need to pack at least one copy of each of 
their segments into progeny virions during budding. For influenza viruses two different 
hypotheses of how this occurs has been proposed. According to the first one each 
individual genomic RNA segment has its own specific packaging signal that directly 
interacts with proteins associated with the viral membrane (e.g. matrix protein) or 
mediates inter-segment specific interactions resulting in a complex of the differently-
sized RNPs that is ready to be packaged. The second, less-favored hypothesis assumes 
random packaging of segments. In this scenario the packaging signal is conserved 
between the segments. Random packaging scheme of segmented viruses would less 
efficiently result in infectious viruses with at least one copy of each individual segment 
than the specific packaging scheme. This drawback could be overcome by packaging 
excess number of segments into a virus particle in order to increase the likelihood of 
obtaining at least one copy of an individual segment into the progeny virion.  The 
segment-specific packaging scheme is currently more favored in the case of influenza 
viruses since it has been shown that the RNA sequences that mediate packaging are 
different for the different segments. These regions consist of not only NTRs but also 
ORFs of individual RNA segments (Hutchinson et al., 2010). However, bunyavirus 
minigenomes, which consist only of NTRs and lack ORFs of viral origin, can be 
packaged into recombinant virions by superinfecting the minigenome-transfected cells 
with wild-type virus (Blakqori et al., 2003; Flick et al., 2003; Flick et al., 2004; Flick et 
al., 2003; Kohl et al., 2006). As shown for BUNV and UUKV, the promoter strengths of 
these minigenomes are in the order of M > L > S but packaging efficiencies are in the 
order of L > M > S showing that the NTRs of each segment play their specific roles in 
packaging stage (Flick et al., 2004; Kohl et al., 2006). Different packaging efficiencies of 
segment-specific NTRs may relate to the different sizes of the individual native segments; 
the largest L segment needs the strongest packaging signal to be efficiently incorporated 
into progeny viruses. When studying packaging of RVFV RNA segment, conflicting 
results have been obtained. In one study it was shown that the packaging of L and S 
segment RNAs were dependent on wild-type M segment NTRs (Terasaki et al., 2011). 
Contradictory to this, a viable two-segmented recombinant form of RVFV without the M 
segment RNA was recently obtained. In this arenavirus-like RVFV, glycoproteins were 
cloned into the S segment replacing the non-essential NSs protein (Brennan et al., 2011). 
A study performed with BUNV indicated that when the NTRs of L segment were 
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replaced by those of M segment, the recombinant virus was infectious (Lowen et al., 
2005). This in turn indicated that at least two copies of M segment NTRs can be packaged 
into progeny virus showing a degree of randomness in the packaging. While it is well-
established that NTRs are required for packaging of bunyaviral RNA segments, the actual 
sizes of the RNA segments may contribute to the specificity of packaging of each 
individual RNA segments. 
The ability to produce infectious VLPs directly from cloned viral proteins allows 
mutational analysis of viral proteins related to virus assembly. By these means it has been 
demonstrated that Gn-CT is necessary the packaging of RNP in UUKV (Overby et al., 
2007a) and RVFV (Piper et al., 2011). For UUKV, the most C-terminal residues of Gn-
CT are essential for RNP incorporation into VLPs whereas for RVFV it is the N-terminal 
part of Gn-CT. In the case of RVFV it was shown that Gn-CT can bind and package L 
and N proteins independently but for efficient release of VLPs the N-encapsidated 
genomic RNA, but not L protein, is required. Since N protein of phleboviruses has no 
sequence-specificity in its RNA binding activity, it was hypothesized that it is the Gn-CT 
that recognizes a packaging signal in the genomic RNA thus playing an indispensable 
part in the formation of infectious virions (Piper et al., 2011). In contrast to phleboviruses 
where Gc-CT does not seem to play major role in virus assembly, the N protein of TSWV 
tospovirus can interact with both Gn and Gc (Ribeiro et al., 2009; Snippe et al., 2007).  
However, the predicted Gc-CT of TSWV is much larger than the corresponding Gc-CTs 
of phleboviruses (or hantaviruses) and it is, therefore, likely that it has some functions, 
which are not analogous to other bunyaviruses. 
The Gn-CTs of hantaviruses (ANDV) and nairoviruses (CCHFV) are shown by NMR 
analysis of recombinant Gn-CTs to possess a unique dual CCHC-type ZF-fold (Estrada et 
al., 2009; Estrada & De Guzman, 2011). The structural analysis of this domain indicates 
that it has two individual zinc fingers (coordinating one zinc(II)-ion each), which both 
fold into a conventional ββα conformation. However, unlike typical ZFs of this type, the 
hanta- and nairovirus ZFs associate tightly with each other to form a globular domain. 
The cellular ββα-type ZFs usually form arrays of multiple ZFs as a so called “beads on a 
string” orientation and act commonly as transcriptional regulators. Given the common 
role of cellular ZFs in regulation of RNA or DNA functions it is hypothesized that 
bunyaviral ZFs would recognize viral RNA. Although the ZF domains of CCHFV and 
ANDV have similar structures they differed in the sense that CCHFV ZF was capable of 
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binding viral RNA while ANDV was not (Estrada & De Guzman, 2011). On the other 
hand, the ZF domain of TULV is shown to bind N protein (Wang et al., 2010). Taken 
together these results suggest a role for the ZF domain in the assembly of RNPs into 
progeny viruses. By sequence prediction it can be assumed that orthobunyaviruses and 
tospoviruses also have ZFs in their Gn-CTs (Estrada et al., 2009) (Fig. 5) although those 
are likely to represent different types of ZFs and may, therefore, exert different functions. 
Interestingly, phleboviruses do not contain a predicted ZF fold in their Gn-CT (Fig. 5) or 
anywhere else in the viral proteins (personal observation). Intriguingly, phleboviruses are 
also the only members of Bunyaviridae, which are known to form VLPs in the absence of 
N or RNP (Overby et al., 2006; Piper et al., 2011). 
 
1.2.4.3 Budding and assembly of matrix-protein containing NSRVs  
Irrespective of the packaging mechanism, the influenza matrix protein M1 is most likely 
required for incorporation of the genetic core into progeny virions. The M1 has been 
shown to interact with the viral RNP through direct binding of the nucleocapsid protein 
(Baudin et al., 2001; Noton et al., 2007). It has also ability to bind single-stranded RNA 
nonspecifically (Elster et al., 1997; Wakefield & Brownlee, 1989; Ye et al., 1999; Ye et 
al., 1989) but the role of the RNA-binding activity in RNP recognition is still unclear. M1 
inhibits transcription of purified RNPs in vitro and the activity of influenza transcription 
system in vivo (Perez & Donis, 1998). It is hypothesized that this mode of action of the 
matrix protein is a signal to the viral polymerase to stop producing new viral proteins or 
genomes and to engage in packaging of progeny viruses. The transcription inhibition is in 
many studies attributed to the RNA-binding motif of M1 (Perez & Donis, 1998; 
Watanabe et al., 1996; Ye et al., 1989), which on the other hand is pin-pointed to the 
nuclear localization signal RKLKR of the protein (Elster et al., 1997) (orthomyxoviruses 
replicate in the nucleus). There is also a report suggesting that a zinc finger-containing 
domain of M1 is able to bind RNA (Ye et al., 1989). Peptides encompassing this zinc 
finger are potent inhibitors of viral transcription in vitro and also harbor antiviral activity 
when introduced into infected cells (Nasser et al., 1996; Wang et al., 2011).  
The influenza M1 is not designated for budding, and VLPs can form in the absence of M1 
(Chen et al., 2007). In contrast, the matrix protein Z of arenaviruses, like many other 
matrix proteins of enveloped RNA viruses, is essential for virus budding (Perez et al., 
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2003; Perez et al., 2004). Many arenavirus Z proteins also contain proline-rich late 
domains that mediate budding of VLPs (Perez et al., 2003) and it can bud into VLPs even 
in the absence of other viral proteins. It recruits the nucleoprotein into progeny viruses 
presumably by direct protein-protein interactions (Capul et al., 2011; Casabona et al., 
2009; Eichler et al., 2004; Groseth et al., 2010). It is of interest to note that tacaribe 
arenavirus (TACV) Z protein does not have the conventional proline-rich late domain like 
many other arenaviral Z proteins and, therefore, cannot bud efficiently. However, VLP 
formation of this virus is greatly enhanced by co-expression of the nucleoprotein and this 
phenomenon is dependent on YxxL motif (similar to what is found in hantaviruses) in Z 
protein (Groseth et al., 2010). Like influenza M1, the Z proteins inhibit viral RNA 
synthesis. This has been shown in vivo with reverse genetics systems and in infected cells 
that express Z proteins transiently (Cornu & de la Torre, 2001; Cornu et al., 2004; Lopez 
et al., 2001). For TACV Z protein, the ability of Z protein to bind the viral polymerase 
has been shown to be essential for the inhibitory effect of RNA synthesis (Jacamo et al., 
2003; Wilda et al., 2008). Like influenza matrix protein and most bunyaviral Gn-CTs the 
Z protein contains a zinc finger domain. However, the Z protein zinc finger is different 
from the others, and it is predicted to fold into a RING finger structure (Djavani et al., 
1997). Cellular homologues with RING finger structures function as E3 ubiquitin ligases 
(Matthews & Sunde, 2002), but this activity has not been detected for the RING finger 
domain of Z protein. Conversely it is shown to be required for packing of RNPs into 
VLPs (Casabona et al., 2009) and for the repression RNA synthesis by partially 
mediating interaction with the polymerase (Cornu & de la Torre, 2001; Jacamo et al., 
2003). Cysteine-alkylating zinc finger inactivating chemicals are shown to block 
arenavirus infectivity when applied to virions prior to virus adherence to the host cells 
(Garcia et al., 2000; Garcia et al., 2002; Garcia et al., 2006; Garcia et al., 2009). This 
indicates that the RING finger of Z is required in early stages of arenavirus infectivity 
similarly to what has been shown for retroviruses in which cysteine-alkylating chemicals 
target the zinc finger of the viral nucleocapsid and presumably block the post-entry 
reverse transcription step (Guo et al., 2000; Johnson et al., 2000; Rice et al., 1993; Rice et 
al., 1995). The only evidence for the requirement of Z protein for arenavirus transcription 
comes from a study in which Z protein depletion from infected cells markedly reduced 
mRNA transcription when the depletion was performed in the early stage of infection 
(Garcin et al., 1993). 
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For bunyaviruses that lack a matrix protein these above-mentioned functions need to be 
executed by other viral proteins and a most likely candidates for this are the CTs of 
glycoproteins. When comparing the functions of matrix proteins between 
orthomyxoviruses and arenaviruses it is evident that they differ to large extent even 
between themselves but some analogies to bunyaviral Gn-CTs can be detected. Firstly, 
predictions suggest that all members of family Bunyaviridae except for phleboviruses 
harbor a ZF, which has been shown in the case of orthomyxo- and arenaviruses to inhibit 
viral RNA synthesis. This is probably a signal for the polymerase to switch from 
replication to progeny virus formation. The findings that bunyaviral ZFs can bind RNA 
and N protein certainly support the idea that the ZFs share a crucial function in packaging 
of all NSRVs. Secondly, sequences resembling late domains of arenaviral Z protein, 
which are responsible for the recruitment of a cellular budding apparatus to the site of 
virus budding, can be predicted also in the sequences of CTs of bunyaviruses (e.g. the 
totally conserved YxxL in hantaviruses). 
 
1.3 Hantavirus pathogenesis 
 
1.3.1 Clinical picture of hantavirus-mediated diseases 
 
Hantaviruses cause HFRS in Eurasia (old-world hantaviruses) or HCPS in the Americas 
(new-world hantaviruses). In general, the incubation period between virus encounter 
through rodent excreta and the first signs of a disease is around three weeks. The severity 
of HFRS depends on the causative virus and can be divided into severe (Hantaan virus; 
HTNV), moderate (Seoul virus; SEOV) or mild (Puumala virus; PUUV) disease. The 
clinical course of HFRS can be separated into febrile, hypotensive, oliguric, diuretic and 
convalescent stages. However, it is not uncommon that these different stages are 
indistinguishable and especially with milder forms of HFRS some stages can also be 
absent. The febrile phase is manifested with fever, headache and backache with frequent 
hemorrhages (Table 1). After approximately 4 days it progresses to the hypotensive 
phase, which can last from hours to two days, where the symptoms intensify and nausea 
together with vomiting are more common. In the most severe cases, the hypotensive 
phase can already develop to fatal shock. The subsequent oliguric phase (1 to 16 days) 
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accounts for about half of the deaths seen in HFRS, which are mostly due to renal 
insufficiency, shock and hemorrhages. Dialysis is sometimes required at this stage. 
Patients who progress into the polyuric stage show improved renal function, and full 
recovery is achieved during the convalescent phase, which can last for months (Jonsson et 
al., 2010; Schmaljohn & Hjelle, 1997). 
In Finland, there are 2000-3000 cases of NE (mild HFRS) diagnosed annually. There is 
considerable variability in the disease manifestation from subclinical to lethal infections 
(mortality 0.1%), and it is believed that most infections are subclinical. Genetic 
susceptibility studies in Finnish population indicated a major histocompatibility complex 
haplotype (human leukocyte antigen-B8-DR3) as an important risk factor of a more 
severe course of NE (Makela et al., 2002; Mustonen et al., 1996). The actual mechanism 
of how this genetic variability of individuals affects the disease outcome is unknown, but 
interestingly the same haplotype is associated with many autoimmune diseases (Price et 
al., 1999). 
In contrast to HFRS with disease incidence of up to 50,000 each year in Eurasia, there 
have been only around 500 cases of HCPS in North America altogether but dramatically 
with over 40% mortality. In South America the incidence rate of HCPS seems to be 
higher than in North America but the mortality rate of South American HCPS in is not 
well-defined. The North American HCPS is mainly caused by SNV and is manifested by 
a rapid onset of respiratory failure and cardiogenic shock. A similar febrile phase that is 
associated with HFRS can be identified also in HCPS as well as laboratory findings of 
thrombocytopenia and leukocytosis (Table 1) but a major difference is that vascular 
leakage affects predominantly lungs and in contrast to HFRS kidneys are largely 
unaffected. The average duration of illness is 3-4 days prior to admission, which after 
death often occurs in 1-3 days (Jonsson et al., 2010; Peters et al., 1999; Schmaljohn & 
Hjelle, 1997). In general, the allocation of hantaviruses to old- and new-world 
hantaviruses with different and clear-cut disease manifestations is somewhat obscure 
since predominant renal involvement has also been occasionally associated in HCPS 
caused by other new-world hantaviruses than SNV and also in one case of SNV-caused 
HCPS (Passaro et al., 2001). On the other hand, pulmonary involvement has been 
recognized in PUUV-infected patients (Kanerva et al., 1996; Rasmuson et al., 2011). One 
striking difference between HCPS and HFRS is that even mild HFRS is frequently 
associated with eye pain or myopia (especially in PUUV-infection) whereas in HCPS this 
manifestation is not encountered at all (Schmaljohn & Hjelle, 1997). 
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Table 1. Symptoms and laboratory findings of hantavirus-associated diseases (% of patients) 
   HTNV SEOV PUUV SNV 
disease severe HFRS moderate HFRS mild HFRS (NE) HCPS 
Symptoms     
fever 100 100 98 95-100 
nausea  72-82 61 58-84 71 
cough 44 14 14-32 71 
headache 83-86 42-89 62-90 71 
backache 94-95 85-90 54-82 29 
abdominal pain 23-25 65 43-67 24 
myalgia 69-93 52-73 20-68 100 
dizziness 41-100 7-52 9-33 41 
diarrhea 11-39 24-40 12-20 59 
hemorrhage 31-77 26-48 12-37 0 
     Laboratory findings 
thrombocytopenia 54-100 70-100 50-80 98 
leukocytosis 88-92 41-69 23-57 76 
proteinuria 96 94 94-100 40 
hematuria 27-86 27-73 58-85 57 
oliguria 59-74 37-46 54-83 n.d 
polyuria 87-92 63 96-97 n.d 
     
Mortality 5-15 < 1 < 0,1 > 40 
     
Data are deduced from Kim et al., 1995 and Lee, 1989 in the case of HTNV and SEOV; Lahdevirta, 1971, 
Mustonen et al., 1994 and Settergren et al., 1989  in the case of PUUV; and Duchin et al., 1994 and Khan et 
al., 1996 in the case of SNV.  n.d. = not determined. 
 
1.3.2 Vascular leakage 
 
The hallmark of hantavirus-caused HFRS and HCPS is vascular permeability, which in 
the case of HFRS leads to microvascular hemorrhage often associated with kidney failure 
and in the case of HCPS to acute pulmonary edema. The endothelial cells lining the walls 
of the microvasculature are known to be the prime targets of the virus. Although there is 
no evidence for cytopathic effects (CPE) either in the infected endothelium in vivo or in 
experimental infections of endothelial cell cultures (Chen & Cosgriff, 2000; Mackow & 
Gavrilovskaya, 2009) several causes for the increased vascular permeability in HFRS and 
HCPS have been suggested (see later sections). The studies of hantavirus pathogenesis 
have been greatly hampered by the lack of appropriate animal models. Infection of Syrian 
hamsters with ANDV induces a disease resembling HCPS in humans and could, 
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therefore, be a model virus for animal studies. However, SNV is not infectible in 
hamsters (Hooper et al., 2001; McElroy et al., 2004; Wahl-Jensen et al., 2007). 
 
1.3.2.1 Thrombocytopenia  
Acute thrombocytopenia (low platelet counts; Table 1) is a common feature to both 
HFRS and HCPS. Since platelet function is required for normal blood coagulation and 
inhibition of internal hemorrhage due to vascular injury, thrombocytopenia may be 
directly involved in pathogenesis of hantavirus-caused diseases. Thrombocytopenia can 
be caused either by diminished platelet production due to defects in mature 
megakaryocytes or abnormally high consumption of platelets in the bloodstream. Partly 
because increased levels of normally functioning megakaryocytes and partly because 
platelets with low survival times have been detected in HFRS-patients, it is believed that 
the low platelet counts associated with hantavirus-mediated diseases are due to their 
excessive consumption (Chen & Cosgriff, 2000). One reason for the excessive 
consumption of coagulation factors (e.g. platelets) is disseminated intravascular 
coagulation (DIC) but this is only present in the more severe cases of HFRS (Chen & 
Cosgriff, 2000). Since thrombocytopenia is a common finding in hantavirus-infected 
patients (Table 1), other explanations for its development are needed. Recently, it was 
demonstrated that endothelial cell cultures infected with pathogenic hantaviruses adhere 
quiescent platelets to their surface (Gavrilovskaya et al., 2010). The interaction between 
platelets and the infected-cell surface can be explained mechanistically by the fact that 
platelets express integrin β3, which is shown to be a receptor for pathogenic hantaviruses 
(see 1.2.2.1), on their cell surface and could, therefore, bind directly to endothelial cell 
surface-expressed viral glycoproteins (Mackow & Gavrilovskaya, 2009). A different 
explanation for the high platelet consumption could be the presence of circulating virus-
specific immune complexes, which were shown to be attached to platelets during the 
onset of HFRS (Chen & Cosgriff, 2000). Immune complexes bind platelets either directly 
or via virus, which are attached to the circulating platelets through integrin β3 
(Gavrilovskaya et al., 2010). Immune complex-bound platelets may then be destined for 
destruction by complement attack or phagocytosis (Chen & Cosgriff, 2000). 
Thrombocytopenia is also detected in NE, where systemic hemorrhage is not that 
common (Table 1). This suggests that while thrombocytopenia could be a contributing 
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factor to hantavirus pathogenesis, it is definitely not the only reason for the development 
of the disease. 
 
1.3.2.2 Cytokine storm 
In addition to thrombocytopenia, another common feature of HFRS and HCPS 
pathogenesis is a widespread activation of pro-inflammatory responses sometimes 
referred to as “cytokine storm” (Mackow & Gavrilovskaya, 2009). It involves marked up-
regulation of various cytokines that could have detrimental effects on microvascular 
functions. Up-regulation of TNF-α seems to be one factor that correlates with disease 
severity (Chen & Cosgriff, 2000; Linderholm et al., 1996b; Mori et al., 1999). By 
analyzing genetic susceptibilities to more severe hantavirus-mediated diseases an 
association with TNF-α gene (TNF2 gene) polymorphism was detected. Individuals with 
the TNF2 allele have a stronger TNF-α promoter and thus higher levels of TNF-α 
production (Borges et al., 2010; Kanerva et al., 1998; Maes et al., 2006; Makela et al., 
2001). The persistence of SEOV in rat host may be due to lower level of pro-
inflammatory responses to infection as compared to humans (Easterbrook et al., 2007; 
Easterbrook & Klein, 2008), and more specifically the persistence of PUUV in bank voles 
in endemic areas may be due to TNF-α promoter mutations resulting in lower level of 
TNF-α production in the rodents (Guivier et al., 2010).   
Interleukin (IL)-6 is another cytokine with high importance in hantavirus pathogenesis. 
IL-6 is invariably up-regulated in hantavirus-associated diseases (Klingstrom et al., 2002; 
Linderholm et al., 1996b; Mori et al., 1999), and has been linked to a more severe disease 
outcome in both NE and HCPS (Borges et al., 2008; Makela et al., 2004; Outinen et al., 
2010). Besides having direct effects on vascular endothelium, TNF-α and IL-6 are known 
to induce the production of nitric oxides (NO). Elevated levels of NO have been detected 
in HCPS (Davis et al., 2002) and NE (Klingstrom et al., 2002; Linderholm et al., 1996a) 
and they have negative, inotropic effects on cardiac functions (Finkel et al., 1992). 
Increased NO could play a role in the development of hypotension by promoting cardiac 
dysfunction detected in HCPS (Hallin et al., 1996; Saggioro et al., 2007) and also in NE 
albeit at a clearly lower level (Makela et al., 2009).  
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1.3.2.3 Immune system 
It is well established that immune responses play a role in the pathogenesis of HFRS. The 
severity of HTNV-caused HFRS clearly correlates with increased amounts of virus-
specific immune complexes peaking at the hypotensive phase of the syndrome. Immune 
complexes activate complement, which can promote vascular leakage by activating 
cytokine-producing monocytes or by direct attack on the endothelium (Chen & Cosgriff, 
2000). The level of complement activation is associated with severity of NE also in 
PUUV-infected patients, but conflicting results have been obtained indicating that either 
the classical (Paakkala et al., 2000) or the alternative route (Sane et al., 2011) act as the 
primary mode of complement activation. A recent finding indicates that elevated levels of 
a Mac-2-binding protein (Mac-2-BP; 90K) correlate with complement activation and, 
thus, disease severity in PUUV-infected patients. Interestingly the same protein has been 
suggested to bind hantaviruses through glycoprotein Gn (Hepojoki et al., personal 
communication). This is a protein that possesses immunostimulatory activity (Ullrich et 
al., 1994), but its significance in hantavirus pathogenesis is still unknown.  
Cytotoxic CD8-positive T cells (CTLs) may also play a role in hantavirus pathogenesis 
especially in HCPS. The amount of CTLs correlate with the severity of HCPS (Kilpatrick 
et al., 2004) and are also elevated in the acute phase of HFRS (Chen & Yang, 1990; 
Tuuminen et al., 2007). There is genetic susceptibility to more severe HCPS or NE, 
namely HLA-B*3501 or HLA-B8-DR3 haplotypes, respectively (Kilpatrick et al., 2004; 
Mustonen et al., 1996). These haplotypes may have a link the more severe disease 
outcome via antigen presentation and, thereby, possibly to the activation of CTLs. 
Another factor that may have an impact on the levels of CTLs is down-regulation of 
immunosuppressant transforming growth factor (TGF)-β, which is observed in HCPS 
(Borges et al., 2008). The elevated amounts of CTLs could increase vascular leakage in 
patients (Terajima et al., 2007) as has been shown in vitro for hantavirus-infected 
endothelial cells (Hayasaka et al., 2007). On the other hand, it was recently shown that 
proliferating immune cells (T and B cells) do not contribute to ANDV pathogenesis in 
Syrian hamsters (Hammerbeck & Hooper, 2011).  
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1.3.2.4 Direct virus infection-caused dysregulation of endothelial cell functions 
Recent evidence shows that ANDV-infection in capillary lung endothelial cells causes an 
increase in cellular permeability that is exerted through up-regulation of vascular 
endothelial growth factor (VEGF), which subsequently promotes down-regulation of 
vascular endothelial (VE)-Cadherin, a major component of endothelial cell adherent 
junctions (Shrivastava-Ranjan et al., 2010). It has also been shown that exogenous VEGF 
increases the permeability of pathogenic hantavirus-infected human umbilical vein 
endothelial cells (HUVECs) through VE-Cadherin down-regulation (Gavrilovskaya et al., 
2008; Gorbunova et al., 2010; Gorbunova et al., 2011). Interestingly, pharmacological 
inhibitors to VEGFR2 and Src kinase inhibit permeabilization of VEGF-induced, virus-
infected endothelial cells (Gorbunova et al., 2011). It has been proposed that the VEGF-
induced vascular hyperpermeability facilitated by hantavirus infection is due to 
inactivation of β3 integrins by the virus and subsequent deregulation of VEGFR2 on the 
cell surface (Mackow & Gavrilovskaya, 2009).   
 
1.3.2.5 Integrins 
It has been suggested that pathogenic and non-pathogenic hantaviruses differ in their 
receptor usage by binding β3 or β1 integrins, respectively (Gavrilovskaya et al., 1999; 
Gavrilovskaya et al., 2002). If this is the case, it underlines the role of β3 integrin in 
hantavirus pathogenesis. SNV has been found to bind human and hamster but not murine 
or bovine β3 integrins (Matthys et al., 2010) making it possible that hantavirus persistence 
in rodents could be due to their inability to regulate the activity of rodent β3 integrin. As 
discussed above, the inhibition of β3 integrin functions by hantaviruses could be linked at 
least to thrombocytopenia and direct endothelial cell permeabilization by virus infection. 
However, the β3 interaction does not explain why even pathogenic hantaviruses 
dramatically differ in their potential to cause disease in man. On the other hand, while 
TULV is often considered non-pathogenic and is suggested to have β1 integrin specificity 
(Gavrilovskaya et al., 2002); there is an implication linking it to a mild HFRS-type 
disease (Klempa et al., 2003) making the clear-cut categorization of hantaviruses to 
pathogenic and non-pathogenic viruses with different receptor usage somewhat obscure.  
Furthermore, the pathogenesis of ANDV in Syrian hamsters is not attributed to its 
glycoproteins since a reassortant virus containing L and S segments of ANDV and M 
segment of SNV (non-pathogenic in Syrian hamsters) was still capable of causing the 
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disease (McElroy et al., 2004). This result is contradictory to the idea that vascular 
leakage caused by hantaviruses could be due to virus glycoprotein-mediated regulation of 
integrins. 
  
1.3.3 Renal failure in NE 
 
Kidney dysfunction is the hallmark of HFRS but is not often found in HCPS. Proteinuria 
is almost always present in HFRS-patients and can be caused either by lowered 
glomerular filtration rate or damage in the proximal tubular cells of the kidneys. Both of 
these cases seem to contribute to acute renal failure in NE (Ala-Houhala et al., 2002; 
Settergren et al., 1990). The tubular proteinuria is even found to persist years after the 
acute disease (Miettinen et al., 2009). Tubulointerstitial nephritis involving cytokines 
(e.g. TNF-α) and cell infiltrates is typical in NE (Mustonen et al., 1994; Temonen et al., 
1996). Interestingly, NE can be mimicked in a macaque model to a great extent where 
degeneration of the tubular epithelial cells co-localize with PUUV antigens and virus-
specific CD8-positive T cells (Klingstrom et al., 2002; Sironen et al., 2008). The role of 
CTLs in the pathogenesis of NE is also suggested by the fact that there is up-regulation of 
perforin, granzyme B and markers for epithelial cell apoptosis in serum of acute NE-
patients (Klingstrom et al., 2006). The detection of hantavirus antigens in tubular 
epithelial cells is not restricted to animal models since both HTNV and PUUV antigens 
have been found in renal tubular cells of HFRS-patients (Groen et al., 1996; Hautala et 
al., 2002; Kim et al., 1993; Sironen et al., 2008) strengthening the idea that they may 
directly cause degenerative effects or attract T cells to attack the renal tubular system. A 
recent study indicated that pathogenic old-world hantaviruses can infect, in addition to 
tubular epithelial cells, also glomerular endothelial cells and podocytes of human kidney, 
and disrupt cell-to-cell contacts in all of these cell types (Krautkramer et al., 2011). This 
was suggested to decrease the barrier functions of the kidney and be therefore the direct 
cause of proteinuria.  
As previously discussed, hantaviruses do not readily cause CPE in cellular monolayers in 
vitro (Hardestam et al., 2005).  However, in some kidney epithelial cell lines (Vero E6 
and HEK293) apoptosis has been reported in response to hantavirus infection (Kang et 
al., 1999; Markotic et al., 2003). The best studied virus in this respect is TULV, which 
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causes apoptosis in Vero E6 cells through a mechanism involving ER stress, caspase-8 
activation and Poly(ADP-ribose) polymerase (PARP) cleavage (Li et al., 2004; Li et 
al., 2005). It was also shown that exogenously applied TNF-α elevates the amount of N 
protein and apoptosis in infected cells (Li et al., 2004). TNF-α is a pro-inflammatory 
cytokine known to exert its functions through up-regulation of Nuclear factor (NF)-κB 
transcriptional regulator and causes apoptosis in cells where normal NF-κB activation is 
impaired (Liu, 2005). Intriguingly, transiently expressed hantaviral N protein is capable 
of blocking TNF-α mediated NF-κB activation (Taylor et al., 2009a; Taylor et al., 
2009b). The N protein does not cause apoptosis by itself even in a TNF-α treated cells, 
but in the natural virus infection, in the presence of ER stress, or during possible up-
regulation of other pro-apoptotic factors, the situation may be different. In SEOV-infected 
macrophages of rat origin NF-κB mediated responses are blocked, which in that context 
was suggested to be one of the mechanism how the virus counteracts pro-inflammatory 
state of the host in order to promote the persistence in its natural reservoir (Au et al., 
2010). Taken together renal dysfunction associated with hantavirus-infections involves 
epithelial cell damage, which may occur via virus-induced apoptosis or induced the 
recruitment of CTLs to the tubular epithelium. 
    
1.3.4 Innate immunity responses 
 
Innate immunity is highly important in combating virus infections.  
Interferons (IFN) are cytokines that stimulate anti-viral state of host cells by up-regulating 
various genes related to restriction of viral replication. Of these genes MxA is probably of 
highest importance. IFNs also promote humoral and cellular immunity of the host 
organism, which generally counteract virus infections. Although immune responses 
contribute to hantavirus pathogenesis (1.3.2.3), efficient immune responses are necessary 
for the host to achieve virus clearance. Infected cells use pattern recognition receptors 
(PRRs) to detect the invading virus and to induce signaling pathways leading to e.g. type 
I IFN (IFN-α and -β) production (Brennan & Bowie, 2010). Viruses need to inhibit these 
pathways in order to be viable, and hantaviruses make no exception to this rule. All 
hantaviruses studied so far induce type 1 IFNs in infected cells but they vary in the extent 
and duration of IFN production and subsequent innate immunity response. Clearly, non-
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pathogenic PHV differs from other hantaviruses in its inability to block early IFN 
production, which leads to early restriction of PHV replication in immune-competent 
cells (Alff et al., 2006; Geimonen et al., 2002; Handke et al., 2009; Matthys et al., 2011; 
Spiropoulou et al., 2007). Furthermore, TULV is a more potent inducer of MxA 
expression than HTNV in HUVECs (Kraus et al., 2004), suggesting that the ability of 
hantaviruses to inhibit innate immunity may actually relate to their various degrees of 
pathogenicity.  
The viral determinants resulting in inhibition of innate immunity have been widely sought 
thereafter. The CT of hantaviral Gn, when transiently expressed, has been associated with 
inhibition of IFN regulatory factor 3 (IRF-3)-mediated IFN-β production. This effect has 
been shown for Gn-CTs of NY-1V and TULV, but not for PHV, and is attributed to the 
C-terminal part of the protein (Alff et al., 2006; Alff et al., 2008; Matthys et al., 2011). A 
possible drawback of the studies involving transient expression of Gn-CT is its 
localization in cells that may drastically differ from wild-type Gn in infected cells, 
although transient expression of full-length glycoprotein precursor in the case of SNV has 
also been shown to block IFN-β induction (Levine et al., 2010). The innate immunity 
induction in studies involving Gn-CT was achieved by over-expressing Retinoic acid 
receptor I (RIG-I). RIG-I is a PRR that recognizes double-stranded RNA or tri-
phosphorylated termini of RNA molecules. The hantaviral genomic RNA termini are 
monophoshorylated (Garcin et al., 1995, Wang et al., 2011) and instead of genomic RNA 
it was found that double-stranded secondary structures in N protein ORF RNA are 
responsible for activation of RIG-I during hantavirus replication (Lee et al., 2011). In any 
case, recent evidence indicates that TULV Gn-CT could also block IFN-β production 
stimulated by other factors than RIG-I (Wang et al., personal communication). The same 
group that performed the initial studies showing that Gn-CT inhibits innate immunity also 
reported that the Gn-CT of pathogenic hantaviruses are destined for degradation by the 
proteasome; a phenomenon, which may have relevance in viral antigen presentation by 
infected cells to the immune system (Geimonen et al., 2003a; Matthys et al., 2011; Sen et 
al., 2007).  However, a later study showed that the Gn-CTs of the less virulent PHV and 
TULV are also degraded (Wang et al., 2009). Degradation was shown to be dependent on 
the C-terminal transmembrane domain, which is proposed to act as signal sequence for 
Gc. In addition to glycoproteins, a nonstructural protein expressed from the S segment 
(NSs) of PUUV and TULV can also inhibit the IFN-β promoter (Jaaskelainen et al., 
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2007). Furthermore, hantavirus infection or transient expression of its glycoproteins can 
block later stages of innate immunity following IFN-β production (Levine et al., 2010; 
Spiropoulou et al., 2007). 
Hantaviruses are typically propagated in Vero E6 cells prior to their usage in downstream 
experiments. Vero E6 cells are considered immuno-deficient since they carry a defect in 
their type 1 IFN genes (Diaz et al., 1988; Mosca & Pitha, 1986), which is a likely reason 
for their high susceptibility to hantavirus (and other virus) infections. However, recent 
studies have shown that the supernatants of hantavirus-infected Vero E6 cells contain, in 
addition to infectious viruses, also type III IFNs (IFN-λ), which can elicit similar antiviral 
responses than type 1 IFNs. An IFN-λ mediated antiviral response was shown in 
epithelial cells which were infected with Vero E6-propagated hantaviruses. However, a 
similar response to hantavirus-containing supernatants was not detected in endothelial 
cells since these cells lack the IFN-λ receptor (Prescott et al., 2010). This finding makes 
the studies and conclusions of induction of innate immunity by hantaviruses at least in 
epithelial cells debatable. The validity of research around hantavirus-induced innate 
immunity is also debated by the fact that different sub-strains of PUUV are remarkably 
different in eliciting innate immunity induction in cells, which indicates that spontaneous 
mutations in the viral genome obtained through passaging of the viruses in cell cultures 
are likely to affect the outcome of immune responses (Sundstrom et al., 2011)  
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2 Aims of the study 
 
• To study the signaling pathways involved in TULV-induced apoptosis and to 
investigate the potential of other hantaviruses to cause apoptosis in vitro  
• To identify and characterize the interactions between hantaviral glycoproteins Gn 
and Gc with ribonucleoprotein 
• To study the role of free thiols in hantavirus entry into host cells 
• To explore the functions of the zinc finger domain in Gn glycoprotein during virus 
entry and assembly 
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3 Materials and methods 
 
3.1 Materials 
 
3.1.1 Cell cultures 
 
Vero E6 cells (green monkey kidney epithelial cell line; ATCC: CRL-1586) and BHK-21 
(baby hamster kidney cell line; ATCC: CCL-10) were grown in minimal essential 
medium supplemented with 10% or 2% heat-inactivated fetal calf serum, respectively, 
and 2 mM glutamine, 100 IU/ml of penicillin and 100 μg/ml of streptomycin at 37 °C in a 
humidified atmosphere containing 5% CO2.  
 
3.1.2 Viruses  
 
TULV (Moravia strain 5302), TOPV, SEOV and PUUV (Sotkamo strain) were 
propagated in Vero E6 cells at titers of 104-107 focus forming units (FFU)/ml conditioned 
medium. Viral titers in supernatants of infected cells were determined as previously 
described (Kallio et al., 2006). Briefly, 10-fold diluted supernatants were applied onto 
Vero E6 cells in a 10-well microscopic slide and stained with virus-specific antibodies 3 
days post infection (d.p.i.). To radiolabel the viral proteins, infected Vero E6 cell cultures 
were starved for 1 h at 37 °C in methionine- and cysteine-depleted medium, and 
propagated with a 1 mCi mixture of [35S]-cysteine and [35S]-methionine (Wallac Perkin-
Elmer) for 3 days at 37 °C. For purification and concentration of viruses, cell culture 
medium passed through a 0.22 µm filter (Millipore) was concentrated by pelleting 
through a 30% (w/v) sucrose cushion (27,000 r.p.m., 2 h, 4 °C, in a Beckman SW28 
rotor) and suspended in TBS (50 mM Tris pH 7.5, 150 mM NaCl) or HBS (25 mM 
HEPES pH 7.5, 150 mM NaCl). UUKV was propagated in BHK-21 cells, conditioned 
medium was collected at 3 d.p.i. and stored in aliquots at –70 °C for later use. UUKV 
stocks (~108 plaque forming units {p.f.u.}/ml) were diluted 104-fold for inactivation 
analysis with thiol-reacting reagents in BHK-21 cells or tenfold in Vero E6 cells.  
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3.1.3 Peptide synthesis 
 
N-terminally biotinylated GnN, GnM, GnC and Gc-CT peptides  together with the ZF 
domain (Table 2) were synthesized in a 25 µmol scale on a MultiPep synthesizer 
according to the manufacturer's protocol (Intavis AG) with standard Fmoc chemistry. The 
full-length Gn-CT peptide was synthesized using Applied Biosystems peptide synthesizer 
433A with Fmoc chemistry. Salt removal from peptides was done in a C18 reversed-
phase column (Supelco Discovery; Wide Pore) using a steep 0–70 % acetonitrile–H2O 
gradient in 0.1 % TFA, and by collecting the main peak. The fraction containing the 
peptide of interest was verified by mass spectrometry (MALDI-TOF; AutoFlex III, 
Bruker) for GnN, GnM, GnC and Gc-CT. The correct size of Gn-CT peptide was verified 
by Tris/Tricine SDS-PAGE (result not shown).  
Table 2. Sequences of peptides used in this study. 
 
 
3.1.4 Peptide array synthesis 
 
MultiPep synthesizer was used for synthesis of SPOT peptide arrays by Fmoc chemistry 
according to the manufacturer's instructions. Hantavirus Gn-CTs were synthesized on an 
amino-functionalized cellulose membrane as 16- or 18-residue long overlapping peptides 
with a three-residue shift. The 18 carboxyl-terminal residues containing the predicted Gc-
CT were also synthesized. Sequences corresponding to Gn-CTs of TULV and PUUV 
were also synthesized in CelluSpot™ format as 20-residue long peptides on MultiPep 
(Intavis Ag) and the slides were printed with SlideSpotter (Intavis Ag), all according to 
the manufacturer’s instructions as described (Beutling et al., 2008).  
 
Peptide 
name 
Peptide sequence 
Gn-CT SKYNTDSKFRILVEKVKKEYQKTMGSMVCEVCQYECETAKELESHRKSCSIGSCPYCLNPSEATPSALQAHFKVCKLTSRFQ
ENLKKSLTMYEPMQGCYRTLSLFRYRSR 
GnN KVKKEYQKTMGSMVCEVC 
GnM QAHFKVCKLTSRFQENLKK 
GnC EPMQGCYRTLSLFRYRS 
ZF MVCEVCQYECETAKELESHRKSCSIGSCPYCLNPSEATPSALQAHFKVCKL 
Gc-CT PRRPSYKKDHKP 
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3.1.5 Protein synthesis 
 
The N protein of PUUV and TULV was expressed and labelled radioactively 
([35S]methionine; Wallac, Perkin-Elmer) in rabbit reticulocyte lysates (TnT Quick; 
Promega) using plasmids harbouring the virus-specific S segment under the T7 promoter. 
Recombinant, baculovirus-expressed PUUV N protein was a kind gift from Reagena Ltd., 
Finland. The RNPs of PUUV and TULV were purified by gel permeation from virions 
pelleted through a sucrose cushion as described recently (Hepojoki et al., 2010). The Gn-
CTs of PUUV and TULV were expressed as glutathione S-transferase (GST) fusion 
proteins in E. coli according to protocols of the manufacturer (GST Gene Fusion System 
Handbook, Amersham Bioscience 18-1157-58 Edition AA). The expression plasmids for 
GST-tagged Gn-CTs were constructed by inserting respective Gn-CT fragments (residues 
526-637 of PUUV and 521-632 of TULV) into the pGEX-4T-3 vector (GE Healthcare). 
GST-fusion proteins were purified by glutathione (GSH) Sepharose 4B beads (Amersham 
Pharmacia, GE Healthcare).  
 
3.1.6 Nucleic acid synthesis 
 
The genomic PUUV S segment was in vitro transcribed (TranscriptAid™ T7 High 
Yield Transcription Kit; MBI Fermentas) from a pGEM-T plasmid containing the 
respective sequence information under a T7 promoter. The PUUV S segment together 
with an unrelated RNA (unRNA) of similar size (included in TranscriptAid™ T7 High 
Yield Transcription Kit; MBI Fermentas) were radioactively labeled with 32P-UTP 
(Wallac PerkinElmer) during transcription and purified using Tripure (Roche). The 42-
mer single-stranded DNA represented the 3´-end of the genomic PUUV S segment: 5´-
TCCAGACTTTCTCGTAGTAGCTTTTCAAGGAGTCTACTACTA-3´. An IRdye800-
moiety was conjugated to the 5´-end of the oligonucleotide, which was synthesized by 
Oligomer Oy, Finland. 
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3.1.7 Antibodies  
 
PUUV-neutralizing bank vole mAbs 5A2 (Gn-specific) and 4G2 (Gc-specific), human 
mAb 1C9 (Gc-specific) and bank vole mAbs 5E1 and 3C11 (N-specific) have been 
described previously (Lundkvist & Niklasson, 1992; Lundkvist et al., 1993; Lundkvist et 
al., 1996a; Lundkvist et al., 1996b) and were kindly provided by Professor Åke 
Lundkvist, Swedish Institute for Infectious Disease Control and Karolinska Institutet, 
Stockholm, Sweden.  Polyclonal antisera raised against GST fusion proteins of PUUV Gn, 
Gc and N have been described previously (Vapalahti et al., 1995). A mixture of rabbit 
polyclonal antibodies K3 and K4, recognizing UUKV N protein (Kuismanen et al., 1982), 
was kindly provided by Anna Katz (Department of Virology, University of Helsinki, 
Finland). Mouse monoclonal antibodies against phosphorylated form of epidermal growth 
factor receptor (EGFR; cat. # sc-12351) and extracellular signal-regulated kinase (ERK) 
1/2 (cat. # sc-7383) were from Santa Cruz Biotechnology Inc. Mouse monoclonal 
antibody against cleaved poly-ADP ribose polymerase (PARP; cat. # 92679546) and 
rabbit polyclonal antibodies against ERK1/2 (Cat. # 9102) and phosphorylated Akt (Cat. 
# 9267) were from Cell Signaling Technology. The anti-HA mAb was from Abcam. The 
mouse mAb against actin was from Sigma and the IRDye800-conjugated streptavidin and 
secondary antibodies were from LI-COR. Alexa Fluor 680-conjugated secondary 
antibodies were from Invitrogen. 
 
3.1.8 Reagents 
 
Recombinant human tumor necrosis factor-α (TNF-α) was from R&D Systems. Thiol-
reacting reagents N-ethylmaleimide (NEM) and iodocatemide (IAA) were from Sigma. 
Biotin-malemide (B-mal) and 5, 5-dithiobis-(2-nitrobenzoic) acid (DTNB) were from 
Thermo Scientific and Calbiochem, respectively. Micrococcal nuclease (MNase) and 
RNase A were from MBI Fermentas.  
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3.2 Methods 
 
3.2.1 Immunoblotting 
 
Viruses were adhered to confluent cell monolayers for 1 h at 37 ºC. Infected and mock-
infected cells were scraped off into medium, washed twice with phosphate-buffered saline 
(PBS) and lysed in radioimmunoprecipitation (RIPA) buffer containing 50 mM Tris-HCl 
pH 7.5, 150 mM NaCl, 3 mM EDTA, 1% NP-40, and EDTA-free cocktail of protease 
inhibitors (Roche). For analysis of protein phosphorylation, RIPA was supplemented with 
1 mM dithiothreitol (DTT), 1 mM Na3VO4 and 20 mM NaF. The protein concentrations 
of the cell lysates were determined using BCA Protein Assay Kit (Pierce). Laemmli gel 
loading buffer was added into samples, which were denatured at 95 °C for 5 min and 
stored at -20 °C. Samples were analyzed by immunoblotting according to standard 
protocols using SDS-PAGE and detection by enhanced chemiluminescence or infrared-
dye based detection system (Odyssey, Li-COR). 
 
3.2.2 Immunoprecipitation  
 
Immunoprecipitations were performed using lysates of purified PUUV and TULV as the 
source for viral proteins. MAbs were used at 10 µg of antibody and polyclonal antisera 
were used at 20 µl of serum per 5 µl of virus preparation. After overnight incubation at 4 
°C or 1 h at RT in an end-over-end shaker, pull-down of immune-complexes was carried 
out for 2 h with protein G–Sepharose beads (Amersham). Precipitated proteins were 
separated by SDS-PAGE and detected by immunoblotting or alternatively by 
autoradiography when radioactive samples were used. When exogenously applied 
radiolabeled RNA was used substrate for immunoprecipitated proteins, its binding to 
proteins was detected directly from the beads by scintillation counting. 
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3.2.3 Pull-down assays  
 
CT-N interactions: The Gn-CT peptide was coupled to thiopropyl Sepharose 6B 
(Amersham Pharmacia) through free thiol groups and peptides GnN, GnM, GnC and Gc-CT 
were coupled to monomeric avidin beads (Pierce Biotechnology) through their biotin-
moiety. The recombinant N or native RNP was incubated overnight in end-over-end 
shaking at 4 °C with 10 µl of peptide-coupled or control beads in 500 µl HBS. Laemmli 
sample buffer was added, samples boiled and separated by SDS-PAGE. The precipitated 
N protein was detected by either immunoblotting or autoradiography. 
CT-RNA interactions: The glutathione beads-coated GST-fusion proteins and avidin 
beads-coated biotinylated peptides were used in the pull-down experiments of the 
radiolabeled S segment RNA (400 CPM) or unRNA (500 CPM). After 1 h incubation at 
RT and subsequent washes the amount of bead-bound RNA was detected by scintillation 
counting. For the binding of DNA, the IRdye800-conjugated oligonucleotide (100 nM) 
was incubated for 1 h at RT and after two washes the bead-bound DNA was eluted by 
boiling in Laemmli sample buffer. 1 µl of LSB eluate (corresponding to 1 µl bead 
volume) was dot-blotted on nitrocellulose, cross-linked by UV and the amount of 
IRdye800-conjugated oligonucleotide quantified using Odyssey.  
Virus-cell interactions: To assess virus attachment to host cells, confluent Vero E6 
monolayers were incubated with radiolabeled TULV for 30 min at 37 °C. Cells were 
washed twice with PBS and lysed in RIPA buffer for 15 min RT. The cell-bound material 
was separated by SDS-PAGE and the radiolabeled viral proteins were detected by 
autoradiography. 
 
3.2.4 Virus inactivation 
 
Virus preparations were incubated with NEM, B-mal, IAA or DTNB for 1 h at RT. In the 
case of NEM and IAA treatments, the residual reagent reactivity was quenched with 5 
mM GSH for 10 min at RT. UV-inactivation of stock virus was performed on ice in a lid-
less 3 cm diameter culture dish, which was irradiated at 254 nm using a 30 W UV lamp at 
a distance of 10 cm with an exposure time of 30 min. 
 Materials and methods  
51 
 
3.2.5 Sedimentation analysis 
 
The conventional medium of TULV-infected Vero E6 cells was changed to growth 
medium supplemented with 2.5% FCS (pre-filtered through a 100 kDa cut-off filter; 
Millipore) at 3 d.p.i.. At 5 d.p.i., the conditioned medium was concentrated approximately 
100-fold. Viruses were sedimented (25,000 r.p.m., 16 h, +4 °C, in a Beckman SW41 
rotor) in a 0–70% sucrose gradient (in 10 mM HEPES pH 7.4, 100 mM NaCl) and the 
gradient was collected from the bottom in ~600 µl fractions. The protein composition of 
fractions was determined by non-reducing SDS-PAGE with silver staining (PageSilver 
silver staining kit; Fermentas). The sucrose concentration of each fraction was determined 
at 22 °C using a manual Zeiss Opton Abbe refractometer.  
 
3.2.6 Cross-linking of RNA to proteins 
 
Lysates of purified PUUV or TULV were treated with 0.1 U/µl MNase in 50 mM Tris-
HCl pH 7.5 with 5 mM CaCl2 for 1 h at 37 °C. MNase was inactivated with 10 mM 
ethylene glycol tetra-acetic acid (EGTA) for 15 min at RT prior to addition of 32P-labeled 
RNA. After 2 h incubation at RT the RNAs were cross-linked to proteins under a UV 
lamp (similarly to virus inactivation) and RNA cleaved with 10 µg RNase A for 1 h at 37 
°C. The enzyme was inactivated by addition of Laemmli sample buffer, samples boiled 
and proteins separated on 6% SDS-PAGE. To visualize RNA-interacting proteins, the 
gels were subjected to autoradiography or immunoblotting.  
 
3.2.7 Probing peptide arrays  
 
The SPOT peptide array membrane was probed with bacN or PUUV lysate overnight at 
4 °C, washed and peptide-bound proteins detected by N protein-specific mAb 5E1. All 
SPOT peptide reactions were recorded on X-ray film by enhanced chemiluminescence. 
The CelluSPOT glass slides were probed with IRdye800-conjugated DNA for 1 h at RT, 
washed, and bound DNA was detected with Odyssey. 
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3.2.8 Flow cytometry  
 
To quantify the proportion of apoptotic cells, infected and mock-infected Vero E6 cells 
(grown in 25 cm2 flasks) were scraped off with a rubber policeman), washed once with 
PBS, fixed and stored in 70% ethanol at -20 °C. Cells were washed once with PBS and 
incubated with 10 mg/ml RNase A for 10 min at RT. To stain DNA, propidium iodide 
(PI) was added at 25 µg/ml in PBS and samples were stored at +4°C overnight. Cell cycle 
and apoptosis analysis was performed with 20,000 cells by FACSarray flowcytometer 
(BD Biosciences) and the resulting data was analyzed by FACSdiva software (BD 
Biosciences) at the FACS core facility, Biomedicum Helsinki. The equivocal low 
intensity cell debris was not included in the analysis. 
 
3.2.9 Surface plasmon resonance 
 
Peptide-N protein interactions were analyzed by surface plasmon resonance with Biacore 
2000™ (Biacore, GE Healthcare). The CT-peptide was coupled to a CM5 sensor chip 
either through cysteine or lysine residues and biotin-conjugated peptides were captured 
on streptavidin coated sensor chips (SA-chip) following manufacturer’s recommendation. 
The levels of peptide coating were comparable in molecular density of 5000 response 
units (RU) for CT and 1000 RU for biotin-conjugated peptides. The bacN protein diluted 
in running buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM EDTA) was used as 
analyte at various concentrations (20-1000 nM). In the case of ZF-peptide running buffer 
devoid of EDTA and supplemented with 100 µM ZnCl2 was used. Sensorgrams obtained 
from empty reference channel were subtracted from the sensorgrams obtained from 
peptide-coated channels.  
 
3.2.10 UV/visible spectroscopy  
 
The ZF-peptide at 70 µM in 50 mM Tris-HCl (pH 7.0) was mixed with excess of Co(II) 
(1 mM CoCl2). After one minute in Co(II), sulfhydryl-reactive chemicals NEM or IAA (1 
mM) or alternatively EDTA (2 mM) as a control were added, and after reaction time of 
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one minute absorption spectrum of 550-750 nm was recorded in Ultrospec 3000 
spectrometer (Amersham-Pharmacia). The NEM and IAA concentrations were two-fold 
to cysteine residues in the ZF-peptide. 
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4 Results and discussion 
 
4.1 Regulation of cell survival by hantaviruses (I) 
 
4.1.1 Background 
 
Hantavirus infections are not commonly associated with cytopathic effects. However, 
signs/symptoms of tubular epithelial cell degeneration is seen in kidneys of NE-patients 
and in monkeys with NE-like diseases, which could be the underlying cause of acute 
renal failure associated with this disease. Previous studies in our laboratory showed that 
TULV, supposedly non-pathogenic hantavirus, induces apoptosis in Vero E6 cells (Li et 
al., 2004; Li et al., 2005). Apoptosis was confirmed by cell cycle inhibition, caspase 
activation, DNA fragmentation and PARP cleavage. In the present study (paper I) the 
molecular mechanisms of TULV-induced apoptosis were investigated. In addition, since 
apoptosis has thus far only been detected in TULV-infected cells, the cell death-inducing 
potential of a panel of different hantaviruses including NE-causing PUUV, HFRS-causing 
SEOV and the apparently non-pathogenic TOPV was studied.  
 
4.1.2 TULV regulates ERK1/2 cell survival pathway  
 
In the present study the effects of hantavirus replication on the activity of extracellular 
signal-regulated kinases (ERKs), which are ubiquitous proteins belonging to the mitogen-
activated protein kinase (MAPK)-family and constituents of Ras/Raf/MAPK signaling 
pathway were investigated. ERKs consist of two homologous isoforms ERK1 and ERK2 
with molecular weights of 44 and 42 kDa, respectively (referred hereafter as ERK1/2). 
The ERK1/2 activation proceeds through its phosphorylation and is commonly involved 
in cell proliferation and cell survival whereas its inhibition may lead to cell death 
(Mebratu & Tesfaigzi, 2009; Ramos, 2008). ERK1/2 activity was assayed in TULV-
infected Vero E6 cells by immunoblotting using antibodies specific for its phoshorylated 
form. In addition, apoptosis was analyzed by the extent of PARP cleavage and virus 
replication by N protein expression levels both with immunoblotting. Virion production 
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was quantified from the conditioned cell culture supernatant with FFU assay (I, Fig. 1a). 
Reduced activity of ERK1/2 in response to TULV was observed that correlated with 
increasing multiplicity of infection (MOI). As judged by PARP cleavage, apoptosis was 
also induced by the high MOI of virus. However, the reduced activity of ERK1/2 was not 
a consequence of apoptosis since it was also observed in the absence of apoptosis when 
low MOIs were used.  These results showed that TULV is capable of inhibiting cell 
survival pathways in Vero E6 cells and that this is likely to be associated with its potential 
to induce apoptosis. The link between apoptosis and inhibition of ERK1/2 
phosphorylation was substantiated in non-infected Vero E6 cells by the use of apoptosis-
inducing concentration of exogenous TNF-α (100 ng/ml), which in addition to inducing 
PARP cleavage also inhibited ERK1/2 activity (I, Fig. 1b). Moreover, UV-inactivated 
TULV did not inhibit ERK1/2 activity showing that its regulation by TULV is probably 
replication-dependent (I, Fig. 2). This was further alleviated by the observation that 
ERK1/2 inactivation by TULV seemed to be reversible; decreased replication of TULV 
by prolonged infection resulted in concomitant relief of TULV-mediated ERK1/2 
inhibition (I, Fig. 2).  
 
4.1.3 Regulation of ERK1/2 and induction of apoptosis by TOPV, SEOV and 
PUUV  
 
Having established that ERK1/2 can be used as a marker of cell survival in hantavirus-
infected cells the ability of TOPV, SEOV and PUUV to cause ERK1/2 down-regulation 
in Vero E6 cells were tested (I, Fig. 3). TOPV and SEOV inhibited ERK1/2 only at a 
relatively low level and PUUV did not inhibit ERK1/2 at all.  However, the amount of 
ERK1/2 inhibition with TOPV and SEOV directly correlated with the level of virion 
production similarly to TULV (I, Fig. 2). TULV differed from other hantaviruses also in 
that it caused marked CPE as observed by light microscopy (not shown) with concomitant 
total ERK1/2 inactivation in highly prolonged infection of 25 days. The observed CPE 
was most probably a result of extensive apoptosis in TULV-infected cells. Since PARP 
cleavage was not repeatedly detected in cells infected with TOPV, SEOV or PUUV; these 
cells were also analyzed by staining with propidium iodide (PI). PI is a fluorescent dye, 
which binds the cellular genomic DNA facilitating quantitative analysis of DNA 
fragmentation and thus apoptosis by flow cytometry. By this method, apoptosis was 
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evident in TOPV- and SEOV-infected cells but not in mock- or PUUV-infected cells 
(unpublished results, Fig. 6), consistent with the earlier observed inhibition of ERK1/2 by 
TOPV and SEOV. Taken together these results demonstrated that also other hantaviruses 
than TULV can cause apoptosis in Vero E6 cells accompanied by ERK1/2 down-
regulation. However, it seems that only TULV is capable of inducing massive 100% 
apoptosis, which is easily detected by light microscopy.  
 
  
Figure 6. Cell cycle analysis of hantavirus-infected Vero E6 cells. Cells were either mock-infected or 
infected with TOPV, SEOV or PUUV and collected 21 d.p.i. for propidium iodide (PI) staining and flow 
cytometric analysis. The amount of cells in sub-G1 phase correspond to apoptotic cell population and are 
indicated as percentages of total cell population.  
 
When comparing the ability of hantaviruses to produce infectious virions it was evident 
that TULV was produced about 100-times more efficiently than TOPV, SEOV or PUUV 
(I, Fig. 3b).  This suggested that the amount and kinetics of virus replication is likely to 
play a significant role in hantavirus-induced apoptosis. It is possible that also other 
hantaviruses than TULV are capable of inducing more pronounced apoptosis if they 
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replicated more efficiently. The reason for the observed differences in replication 
efficiencies of various hantaviruses is not currently known.  
 
4.1.4 The effect of TNF-α on hantavirus-induced ERK1/2 inhibition  
 
It has been shown that application of exogenous TNF-α augments TULV-induced 
apoptosis (Li et al., 2004). The levels of TNF-α correlate with disease severity in 
hantavirus-infected patients (Chen & Cosgriff, 2000; Linderholm et al., 1996b; Mori et 
al., 1999), and its expression has been detected in the kidneys of NE-patients (Temonen 
et al., 1996). For this reason the effects of TNF-α in respect to ERK1/2 activity in 
hantavirus-infected Vero E6 cells was investigated. Hantavirus-infected and mock-
infected cells were cultured in the presence of low amounts of TNF-α (20 ng/ml) and after 
14 d.p.i. and 25 d.p.i. there was a dramatic inhibition of ERK1/2 in response to TNF-α 
treatment and virus infection (I, Fig. 4). The degree of inhibition correlated with 
replication-efficiency of hantaviruses (I, Figs. 3 and 4) with the exception of PUUV-
infected cells in which ERK1/2 inhibition was elevated with TNF-α even when virion 
production decreased in prolonged infection (25 days). These results corroborate the 
earlier findings with TNF-α in which this cytokine had detrimental effects on the viability 
of hantavirus-infected cells. 
 
4.1.5 TULV regulates also EGFR and Akt (unpublished results) 
 
ERK1/2 is involved in a ubiquitous signaling cascade, which can be activated by various 
stimuli (Ramos, 2008). One of the upstream activators of ERK1/2 is EGFR, a plasma 
membrane receptor that belongs to the family of receptor protein tyrosine kinases. Like 
ERK1/2, the activity of EGFR can be followed by analyzing the extent of its 
phosphorylation by immunoblotting. This was performed in TULV-infected Vero E6 
cells and down-regulation of EGFR activity in response to TULV was detected 
(unpublished results, Fig. 7). The TULV-induced EGFR inactivation took place 
concomitantly with the inhibition of ERK1/2 suggesting that ERK1/2 activity is 
dependent on EGFR. In addition to the Ras/Raf/MAPK pathway, which involves 
ERK1/2, EGFR can also activate a phospatidylinosine 3-kinase (PI3K)/Akt pathway, 
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which also promotes cell survival (Lurje & Lenz, 2009). Activity of this pathway in 
TULV-infected cells was studied by analysing phosphorylated Akt by immunoblotting 
(Fig. 7). Similarly to ERK1/2 and EGFR, inhibition of Akt in TULV-infected cells was 
detected (4 d.p.i.). These results indicate that hantaviruses can down-regulate at least two 
common cell survival signaling pathways via EGFR.  
 
 
Figure 7. Regulation of EGFR and Akt by TULV. Vero E6 cells were TULV- or mock-infected (M) for 4 or 
7 days. Cells were lysed and the same total amount of proteins was subjected to immunoblotting by 
antibodies that recognize phosphorylated (activated) forms of EGFR, Akt and ERK1/2.  
 
4.1.6 Does anoikis play a role in TULV-induced apoptosis?  
 
Non-transformed cells are only viable when anchored on a supportive extracellular 
matrix. Integrins are cell surface adhesion proteins responsible for cell attachment and 
play an indispensable part in cell survival through intracellular signaling in response to 
adhesion. Integrins form a complex with EGFR on the plasma membrane and activate 
EGFR-mediated downstream signaling cascades Ras/Raf/MAPK and PI3K/Akt to 
promote cell proliferation and survival. This type of activity has been shown for many 
different integrins, including hantaviral receptors αVβ3 and α5β1 (Alexi et al., 2011; 
Cabodi et al., 2004). When the cells detach from the extracellular matrix, the pro-survival 
pathways are not activated and cells die due to anoikis, which is a form of apoptosis 
(Chiarugi & Giannoni, 2008). Hantaviruses have a preference towards inactive, bent form 
of integrins (Raymond et al., 2005) and it is highly intriguing to speculate whether the 
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released virions disrupt the pre-formed integrin-extracellular matrix or integrin-EGFR 
complexes on the infected Vero E6 cell surface. This can lead to the observed inactivation 
of cell survival pathways and eventually to anoikis (Fig. 8). The involvement of anoikis in 
TULV-infected cells is supported by observations that up-regulation of apoptosis markers 
correlates with cell detachment from the supportive matrix (personal observation). 
Therefore, it is possible that in addition to ER stress, which has previously been shown to 
be involved in TULV-induced apoptosis (Li et al., 2005), anoikis may also play a role in 
this phenomenon. 
 
 
Figure 8. Anoikis in TULV-infected cells. Adherent cells survive only when they are attached to 
extracellular matrix through integrin receptors that exert pro-survival signals upon adhesion into the cell 
through EGFR activation. Hantaviruses bind to the inactive form of integrins thereby blocking the pro-
survival signaling cascade resulting cell detachment and death (anoikis). P stands for phosphorylation of 
tyrosine residues.  
 
4.1.7 Does hantavirus-induced apoptosis occur in vivo? 
 
Monkeys infected with PUUV develop NE-like symptoms with kidney failure (Sironen et 
al., 2008). Tubular epithelial cell degeneration co-localized with PUUV antigen 
indicating that PUUV has a role in the formation of NE symptoms in monkey. Analysis of 
acute NE kidney biopsies by cleaved PARP immunohistochemistry revealed more 
frequent tubular cell apoptosis in NE compared to patients with other kidney diseases (Li, 
2005). While the amount of samples in the latter study was low and no statistically 
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significant conclusions could be drawn from it, it is possible that apoptosis plays a role in 
the pathogenesis of NE. However, in addition to direct virus replication-caused apoptosis 
(enhanced by TNF-α), also cytolytic T cells could be responsible for the cell death 
observed in vivo as suggested by Sironen et al. (2008).   
 
4.2 The interaction of hantavirus glycoprotein-CTs with RNP (II, IV) 
 
4.2.1 Background 
 
Many enveloped viruses encode a matrix protein, which acts as a bridge between the 
surface glycoproteins and the genomic core of the virus, thus playing an indispensable 
part in the proper assembly of infectious virions (Timmins et al., 2004). However, 
bunyaviruses do not have a matrix protein and, therefore, the interaction between the 
genomic RNA-containing ribonucleoprotein complex (RNP) and the inner surface of the 
viral envelope is thought to take place through the cytoplasmic tails of the surface 
glycoproteins Gn and Gc (see Fig. 1). In the case of hantaviruses this putative interaction 
is also supported by electron cryo-tomography studies (Battisti et al., 2010; Huiskonen et 
al., 2010). Besides that, a direct interaction between glycoprotein CTs and RNP or N 
protein has already been shown for many other bunyaviruses (Overby et al., 2007a; Piper 
et al., 2011; Ribeiro et al., 2009; Snippe et al., 2007).  Furthermore, Gn-CTs of RVFV 
and CCHFV have been suggested to directly bind genomic RNA (Estrada & De Guzman, 
2011; Piper et al., 2011). In papers II and IV, interactions of hantavirus glycoproteins 
with native RNP, recombinant N protein and nucleic acids were analyzed. 
 
4.2.2 Native Gn interacts with RNP through its CT (II) 
 
Conformation-dependent PUUV glycoprotein specific mAbs 5A2 (specific for Gn) and 
4G2 (specific for Gc) were used to identify interactions between glycoproteins and RNP 
in purified virions and RNP was found to be immunoprecipitated by both mAbs (II, Fig. 
1). Co-precipitation of Gn and Gc with both mAbs was also detected, which is not 
surprising since these proteins are known to form a complex in native virions (Hepojoki 
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et al., 2010). However, due to this reason, it was impossible to conclude whether RNP 
prefers either of the glycoproteins. 
To be biologically relevant, the RNP-binding activity of Gn and Gc should be retained in 
their cytoplasmic tails. To study this, full-length 110 and 10 amino acid CTs of PUUV Gn 
and Gc, respectively, were synthesized with standard peptide synthesis chemistry. Their 
ability to bind isolated native RNP or recombinant in vitro translated N protein of PUUV 
and TULV was assessed in a pull-down assay where Gn-CT was coupled to thiopropyl 
beads through thiol-coupling and Gc-CT to avidin-beads through its biotinylated N-
terminus (II, Fig. 5). Both CTs could bind RNP and recombinant N protein of PUUV and 
TULV origin. Furthermore, to study the involvement of CTs in the native interaction 
between glycoproteins and RNP in virions, the co-immunoprecipitation assay (II, Fig. 1) 
was performed in the presence of the CT-peptides (II, Fig. 6). Gn-CT, but not Gc-CT, was 
able to out-compete the native glycoprotein-RNP interaction showing that Gn-CT is 
absolutely required for this interaction.   
 
4.2.3 Gn-CT binds nucleic acids (IV) 
 
In paper II it was shown that the CTs of glycoproteins Gn and Gc can bind RNP and N 
protein. The RNP consists of not only N protein but also genomic RNA and it has 
recently been suggested that Gn-CT of RVFV and CCHFV can, in fact, directly bind 
genomic RNA (Estrada & De Guzman, 2011; Piper et al., 2011). Due to these reasons, 
the RNA-binding ability of Gn- and Gc-CTs was studied (paper IV). The 5A2 and 4G2 
glycoprotein-specific mAbs together with pAbs against Gn and Gc were used to analyze 
RNA-binding potential of the PUUV glycoproteins by immunoprecipitation. The purified 
virus was nuclease-treated and incubated with radiolabeled in vitro transcribed S segment 
of PUUV prior to immuprecipitation. Highest amounts of precipitated RNA were 
obtained by Gn-specific antibodies indicating that Gn can recognize genomic RNA (IV, 
Fig. 3b). The RNA-binding ability of purified TULV proteins was also analyzed by using 
cross-reactive PUUV pAbs (IV, Fig. 3a). However, instead of using PUUV S segment 
RNA, an unrelated RNA was used as the substrate for TULV (IV, Fig. 3c). The TULV 
Gn was capable of binding to unrelated RNA indicating that the RNA-binding activity of 
hantavirus Gn is non-specific, i.e. it is not dependent on a specific RNA sequence or 
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structure. In both of these experiments N protein-specific antibodies were used as positive 
control for RNA binding, but surprisingly there was no significant precipitation of RNA 
with these antibodies. This is probably due to the nuclease-treatment of the sample, which 
could render N protein unrecognizable by antibodies. To assess the RNA-binding activity 
of hantaviral proteins in a more direct way, the applied radiolabeled RNAs were cross-
linked to virus proteins and proteins separated in SDS-PAGE. The RNA-bound proteins 
were identified by autoradiography and immunoblotting (IV, Figs 1 and 2). Radioactive 
bands overlapped with Gn and N protein, but not with Gc, in immunoblots, thus 
confirming the ability of Gn and N to bind RNA. 
Having established that full-length Gn can bind RNA, the next step was to analyze the 
RNA-binding activity of Gn-CTs. GST-fused recombinant Gn-CTs of PUUV and TULV 
were expressed in E. coli and studied for their interaction with the radiolabeled PUUV S 
segment RNA and unrelated RNA by GST pull-down. Also, an IRdye800-conjugated 
single stranded 42-mer DNA was included for comparison (IV, Fig. 4). All nucleic acids 
bound to both CTs but not to GST alone confirming the RNA-binding activity of Gn-CT. 
In addition, these results showed that Gn-CT can also bind relatively short DNA that 
alleviates the nonspecific nature of its interaction with nucleic acids. 
 
4.2.4 Mapping the binding sites of Gn-CT towards RNP, N protein and nucleic 
acids (II and IV)  
 
As discussed in section 1.2.4 hantaviral Gn-CT harbours some conserved regions, i.e. the 
ZF domain and endocytosis motif YxxL, that might exert functions important for virion 
assembly. Therefore it was of interest to determine the binding sites of Gn- and Gc-CT to 
RNP, N protein and nucleic acids. The binding sites for RNP and recombinant 
baculovirus-expressed PUUV N protein (bacN) were analyzed by SPOT peptide arrays. 
The arrays consisted of 16- to 18-mer peptides covering the whole sequence of Gn-CT 
with a 3-residue overlap. The Gn-CTs of PUUV, TULV, PHV and NY-1V together with 
Gc-CTs of multiple hantaviruses were synthesized on a cellulose membrane and probed 
either with PUUV lysate or bacN. The binding of N protein in both cases was detected by 
N protein antibodies and enhanced chemiluminescence. Four different binding domains in 
all Gn-CT sequences were initially detected towards PUUV RNP and bacN. These 
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domains were located on either side adjacently to the ZF domain, in the middle of the ZF 
and in the C-terminus of Gn-CT (II, Fig. 2 and 5). The ability of Gc-CTs to bind N 
protein was also confirmed. The residues important for the RNP interaction in each 
binding domain of PUUV CTs, except for the one that resides in ZF domain, was further 
analyzed by peptide mutagenesis and deletions. The binding site in ZF was not included 
since the whole ZF domain was analyzed separately. Firstly, each individual residue of a 
chosen parent peptide corresponding to one binding domain was mutated to alanine. 
Secondly, one by one amino acid deletions from either side of the peptide were applied 
for all except the C-terminal binding peptide Gn-CT. The peptides were synthesized as 
SPOT peptide arrays, probed with PUUV lysate and RNP binding detected as previously 
(II, Fig. 3). Individual residues important for the RNP interaction could be identified and 
which are highlighted in the Gn-CT alignment (II, Fig. 4). Positively charged residues 
were often important for RNP binding indicating a possible involvement of the negatively 
charged nucleic acid backbone in the interaction. The same peptides, which bound RNP, 
were also shown to bind bacN. However, it is not known whether the bacN preparation is 
absolutely pure of nucleic acids and whether the N protein exists as a complex with non-
viral RNA, which may have co-purified with the protein during its extraction from cells. 
To identify the binding sites of PUUV and TULV Gn-CT towards nucleic acids, a 
CelluSpot peptide array with the same general principle as in the SPOT peptide arrays 
was employed but where the peptides were first synthesized in soluble form and later 
printed on glass slides in array format. The advantages of this methodology over the 
conventional SPOT array technique are the possibility to get multiple identical arrays 
from one round of peptide synthesis and miniaturization of the assay platform. The 
IRdye800-conjugated nucleic acid previously detected to bind Gn-CTs was used as probe, 
and in the case of PUUV Gn-CT three different binding sites that localized similarly to 
the previously determined binding sites for RNP were identified (IV, Fig. 5a). In the case 
of TULV, however, only C-terminal peptides were found to have affinity towards nucleic 
acids. Furthermore this binding region extended beyond the C-terminal RNP binding site, 
which was identified for PUUV Gn-CT, and towards the N-terminus of the protein (IV, 
Fig. 6). In all, it seems that the C-terminal part of hantaviral Gn-CT harbours a conserved 
nucleic acid binding site, which overlaps with the RNP binding site.  
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4.2.5 The binding of Gn-CT to RNP, N protein and nucleic acids is primarily 
mediated by its C-terminal part (II and IV) 
 
Peptide arrays are sensitive for false positive results due to high concentration of peptides 
in a single SPOT and lack of conformational and positional stringency asserted by the 
natural biological context of a peptide. Therefore, the aim was to verify the mapping data 
obtained by peptide arrays with soluble peptides and recombinant proteins. Three 
peptides of PUUV Gn-CT identified as RNP binding peptides were synthesized in soluble 
form (designated GnN, GnM and GnC; see Table 2) together with the ZF domain. Surface 
plasmon resonance assay in which the peptides were immobilized to a Biacore sensor 
chip and bacN was used as the analyte in liquid phase was performed (unpublished 
results, Fig. 9). A concentration-dependent interaction of PUUV to all peptides except the 
ZF was observed. First of all this result confirmed that the peptides, which were identified 
by SPOT arrays as N-binding peptides, were functional also in this type of assay where 
peptide concentration on the chip surface was probably much lower than in the individual 
SPOTs. This result also showed that the ZF domain is unable to bind N protein. This was 
not due to inability of the peptide to bind zinc-ions (see section 4.3). This result 
contradicts the study which suggested that the interaction between Gn-CT and N proteins 
was mediated through an intact ZF domain (Wang et al., 2010). However, our peptide 
mapping data showed that the N protein can interact with Gn-CT through binding sites 
adjacent to the ZF and which were not present in ZF peptide (Table 2). It is, therefore, 
possible that the folding of the ZF domain is important for the binding of N protein 
possibly by bringing the binding sites in Gn-CT closer to each other.    
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Figure 9. Binding of Gn-derived peptides to N protein as measured by surface plasmon resonance assay. 
The Gn-CT was coupled to a sensor chip either through free thiols or free amines. The biotin-conjugated 
GnN, GnM, GnC and ZF peptides were coupled to a streptavidin-coated sensor chip. Baculovirus-expressed 
N protein was injected over the sensor chips at indicated concentrations. The sensograms presented here 
were obtained by subtracting their signal from an empty reference flow cell.  
 
To analyze the binding capabilities of GnN, GnM and GnC peptides further, they were 
coupled to avidin-beads through their biotinylated N-terminus prior to performing pull-
down assays with isolated RNP, in vitro translated N protein and nucleic acids. All 
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peptides bound the recombinant N protein of PUUV and TULV, and GnC showed the 
highest affinity followed by GnM and GnN (II, Fig. 5). The peptides were found to bind 
nucleic acids with similar relative affinity as observed for N protein (IV, Fig. 5b). 
However, in the case of RNP binding, GnM was the weakest binder of PUUV RNP and 
could not bind TULV RNP at all. In contrast, GnN showed RNP binding levels 
comparable to GnC. The reason for the differences between the binding of N protein and 
RNP to GnM and GnN is unknown but the results suggest distinct mechanisms of how Gn-
CT recognizes N and RNP. It is possible that genomic RNA mediates the binding of RNP 
to Gn-CT either directly or by inducing conformational changes in the native N protein.  
For TULV Gn-CT, a GST-tagged recombinant protein lacking the C-terminal part of Gn-
CT including the nucleic acid binding region and the putative endocytosis motif YxxL 
was expressed (IV, Figs 6 and 7b). In pull-down assay, the RNA-binding of this deletion 
construct was observed to be completely abolished; whereas approximately 50% 
remained of its DNA-binding activity as compared to the full-length Gn-CT (IV, Fig. 7c). 
The differences in RNA and DNA binding may be explained by the different sizes of the 
applied nucleic acids. It is possible that the internal binding sites of Gn-CT, located 
adjacent to the ZF, are inaccessible for the larger RNA molecules. These binding sites 
were only detected for PUUV but they could also be involved in the Gn-nucleic acid 
interaction of TULV. Taken together, these results suggest that the C-terminal part of Gn-
CT has the highest affinity towards native RNP, N protein and nucleic acids. 
 
4.2.6 Significance of the interaction of Gn-CT with RNP and nucleic acids in 
virus life cycle   
 
The peptide mapping results indicated that Gn-CT of hantaviruses can bind nucleic acids 
independently of N protein but through the same binding sites. Since the recombinant N 
protein preparations used in these assays may also contain nucleic acids associated with 
the N protein, it is possible that the observed interaction of Gn-CT with N protein and 
possibly also RNP is mediated solely by nucleic acids. Therefore, the involvement of 
nonspecific nucleic acid-mediated binding event in the native Gn-RNP interaction was 
analyzed using the previously described co-immunoprecipitation assay. The virus was 
treated with nucleases prior to immunoprecipitation or alternatively the 
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immunoprecipitation was performed in the presence of excess DNA (unpublished results, 
Fig. 10). In both cases the RNP binding activity of Gn was preserved indicating that 
although Gn binds nucleic acids nonspecifically, this is not solely responsible for its 
interaction with RNP.  
 
 
Figure 10. Involvement of nucleic acids in Gn-RNP interaction. Purified radiolabeled PUUV was either 
treated with micrococcal nuclease (MNase) prior to immunoprecipitation with 5A2 or alternatively 
immunoprecipitation was performed in the presence of extensive amounts of a 42-mer single-stranded 
DNA. The precipitated proteins were separated in SDS-PAGE and detected by autoradiography according 
to their typical migration pattern.  
 
Matrix proteins of NSRVs have been shown to inhibit viral RNA synthesis. In the case of 
influenza M1 matrix protein, this is mediated through its RNA binding motifs (Perez & 
Donis, 1998; Watanabe et al., 1996; Ye et al., 1989). Like discussed in section 1.2.4, 
bunyaviruses do not encode matrix protein, and Gn-CT (at least in the case of 
hantaviruses) is thought to substitute for its activity. Therefore, it is intriguing to 
speculate whether the hantaviral Gn-CT actually regulates viral transcription or 
replication. Inhibition of viral RNA synthesis would act as a signal for the viral 
polymerase or the RNP complex to engage in packaging and assembly of progeny virions 
rather than producing more viral proteins or genomes (Fig. 11). The ZF domain of Gn-CT 
may play the major role in this putative function, similarly to influenza M1 and 
arenavirus Z proteins (Cornu & de la Torre, 2001; Nasser et al., 1996).  In the case of Z 
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protein, no RNA-binding motifs have been identified in the protein but instead its ZF 
have been shown to bind the viral polymerase (Jacamo et al., 2003). 
 
  
Figure 11. Hypothetical scheme of the packaging of hantavirus RNP into progeny viruses. The CTs of Gn 
and Gc form a matrix-type proteinaceous layer underneath the viral envelope in the virions or at Golgi 
membranes (GC) in the infected cells to which viral RNPs bind. The L protein is associated with RNPs but 
is inactive due to RNP-CT interaction.   
 
In order to produce infectious viruses, hantaviruses need to pack at least one copy of each 
of the three differently-sized RNPs into a single virion. The Gn-CT of TULV seemed to 
be interchangeable to PUUV Gn-CT in its binding ability towards RNP, N protein and 
nucleic acids of PUUV origin. In addition, according to SPOT peptide arrays, even Gn-
CTs of HCPS-causing viruses (e.g. NY-1V) can bind PUUV RNP and bacN. This cross-
species binding suggests that the interaction between Gn-CT and RNP is rather 
nonspecific; i.e. there is no specific packaging signal in the individual RNPs and that the 
CTs could possibly interact with all the three viral RNPs independently. The robustness 
of Gn-RNP interaction unorthodoxically implies that complementary RNPs (cRNPs) 
encapsidating positive-stranded viral RNAs are being packaged together with the viral 
RNPs (vRNPs) into progeny virions. However, it is possible that the vRNPs are expressed 
in high excess over cRNPs in infected cells and, therefore, no differentiation of these 
complexes by CTs is needed in order to produce highly infectious virions. The 
nonspecific nature of the CT-RNP interaction can result in virions with multiple copies of 
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individual segments but evidence for this is lacking. However, the high variability in size 
and shape of purified TULV (Huiskonen et al., 2010) is indicative of inconsistent 
numbers of RNPs in the virion.  
 
4.3 Hantavirus infectivity is dependent on free thiols (III) 
 
4.3.1 Background 
 
The biological functions of the ZF domain located in hantavirus Gn-CT remains 
unknown. In addition to the possible role of the ZF in virus assembly its role in hantavirus 
infectivity was addressed (paper III). This is because retroviruses possess a similar dual 
CCHC-type ZF in their nucleocapsid protein, and alkylation of the thiols that coordinate 
zinc-ions results in complete retrovirus inactivation (Arthur et al., 1998; Chertova et al., 
2003; Jenkins et al., 2005; Morcock et al., 2005; Morcock et al., 2008; Musah, 2004; 
Rein et al., 1996; Rice et al., 1993; Rice et al., 1995; Rossio et al., 1998). In addition, a 
similar observation has been made for arenaviruses in which the RING finger domain of 
its Z protein is likely to be required for infectivity (Garcia et al., 2000; Garcia et al., 
2002; Garcia et al., 2006; Garcia et al., 2009). In these two cases the studied thiols are 
located inside the virus envelope but, on the other hand, thiols located on the surface of 
viral glycoproteins can also be exploited in virus entry. They can be substrates for virally- 
or cell-encoded protein disulfide isomerases (PDIs) that act to re-organize disulfide 
linkages in viral glycoproteins in order to facilitate viral entry (Sanders, 2000). The active 
site of PDIs resides in the CxxC motif, which is also found in hantavirus Gc adjacent to 
its proposed fusion peptide (Cifuentes-Munoz et al., 2011; Garry & Garry, 2004; Tischler 
et al., 2005). 
 
 
 
 
 Results and discussion  
70 
 
4.3.2 Hantaviruses are inactivated by thiol-blocking reagents  
 
N-ethylmaleimide (NEM) and 5,5-dithiobis-(2-nitrobenzoic) acid (DTNB) were used to 
probe the role of thiols in hantavirus infectivity. Of these chemicals, NEM is membrane-
permeable and irreversible whereas DTNB is membrane-impermeable and reduction-
labile. PUUV- or TULV-infected Vero E6 cell culture supernatants were treated with 
increasing amounts of the thiol-reagents and the remaining infectivity was analyzed in the 
supernatants by FFU assay (III, Fig. 1 and Table 1). Both reagents could inhibit the 
infectivity of PUUV and TULV but NEM was by far the more virucidal. By using NEM 
at concentrations between 10-100 µM close to 100% inactivation of the virus stocks was 
achieved. The potency of NEM was increased when purified TULV was used, indicating 
a protective effect of serum in virus-containing cell culture supernatants (III, Fig. 1c). 
These results suggested that membrane-permeability of thiol-alkylating reagent, as is the 
case with NEM, may be important for high virucidal efficiency. However since also 
DTNB had significant inhibitory activity the possibility of at least some level of thiol-
disulfide shuffling in hantavirus glycoproteins, required for infectivity, could not be 
excluded. We tested the effect of these chemicals also on UUKV phlebovirus infectivity 
since these viruses do not contain a ZF domain (personal observation). This was achieved 
by infecting Vero E6 cell monolayers with UUKV and TULV (III, Fig. 2).  In the case of 
NEM, excess reagent reactivity was quenched prior to virus adhesion but the membrane-
impermeable DTNB was allowed to react with the cellular PDIs upon infection. Results 
showed that NEM is clearly more virucidal towards hantaviruses than phleboviruses, thus 
supporting a role for the ZF in hantavirus infectivity. In addition, DTNB had no 
measurable inhibitory effect on TULV or UUKV in this assay suggesting that no cellular 
PDI activity is involved in hantavirus or phlebovirus entry. 
 
4.3.3 Inactivation of hantaviruses by NEM retains virion integrity  
 
The mechanism of how NEM inactivates hantaviruses was then investigated by studying 
structural and functional integrity of the virus after inactivation. Firstly, the structural 
integrity of the inactivated virions was studied by sucrose density gradient 
ultracentrifugation (III, Fig. 3). Secondly, the conformational stability of the NEM-treated 
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viral glycoproteins was assessed by immunoprecipitation with conformation-sensitive 
antibodies (III, Fig. 4). Thirdly, cell-binding capacity of the inactivated virus was 
analyzed by binding of radiolabeled virus to Vero E6 cell monolayers (III, Fig. 5). All 
these experiments suggested that virus structure and surface functionality was unaltered 
due to NEM treatment supporting the idea that the inactivating potential of NEM 
probably lies in its ability to traverse the viral membrane. Although it was not the main 
intention in this study; these results also suggested that NEM-inactivated hantaviruses can 
be used to provoke a neutralizing antibody response in affected individuals and they 
could, therefore, be used as vaccines. For retroviruses, where chemical inactivation by 
thiol-blocking reagents is widely studied, the use of thiol-inactivated viruses as vaccines 
has also been investigated (Lifson et al., 2002; Lifson et al., 2004; Lu et al., 2004).     
 
4.3.4 The possible role of the ZF in hantavirus entry  
 
The results obtained by using NEM as hantavirus-inactivating agent supported the idea 
that ZF could in fact be involved in hantavirus infectivity. To obtain some idea of which 
of the viral proteins are subjected to alkylation with NEM, biotinylated maleimide (B-
mal), a mechanistic analogue for NEM, was used. First of all, it was observed that this 
reagent is not as virucidal as NEM (III, Fig. 6a) probably reflecting its bulkier molecular 
composition. Intact and detergent–disrupted sucrose-gradient purified TULV was then 
treated with this chemical and immunoblotting using streptavidin as probe was performed 
to detect the B-mal reacted proteins (III, Fig. 6b). B-mal reacted with Gn, Gc and N 
proteins even in intact viruses indicating that all these proteins have free thiols. N protein 
was clearly more heavily labelled in disrupted virions as compared to intact ones showing 
that B-mal does not cross membranes readily, which could also be the reason for its lower 
virucidal efficiency compared to NEM. In addition to Gn, labelling of Gc and N protein 
was also detected, and, therefore, it was impossible to deduce which thiols were critical 
for virus infectivity. Despite of this, the effect of NEM on the zinc binding capacity of 
previously synthesized PUUV ZF peptide was analyzed (Table 2) in order to determine 
whether NEM is actually capable of destroying the ZF fold in hantaviruses. This was 
done by exploiting the spectroscopic activity of Co(II)-ions, which can functionally 
substitute for Zn(II)-ions in ZF-folds. The Co(II)-ion treated peptide gave a peak at 650 
nm, which was not visible in the presence of EDTA, indicating ion-binding to the peptide 
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(unpublished results, Fig. 12). Treatment with NEM, but not with iodoacetamide (IAA), 
clearly ejected the Co(II)-ion from the peptide. IAA is also a thiol-blocking reagent, 
which in concordance with its inability to destroy the PUUV ZF fold has low inactivation 
potential of hantaviruses in FFU assay (data not shown).    
 
 
Figure 12. PUUV zinc finger peptide metal binding capacity is destroyed by NEM but not by IAA. The ZF 
peptide was folded in the presence of spectroscopically active Co(II)-ion as a substitute for the 
spectroscopically inactive Zn(II)-ion as the metal ligand. Absorption spectrum was recorded from 550 to 
750 nm and a local absorption maximum detected at 650 nm, indicating Co(II) chelation to the peptide. To 
abolish the metal binding capacity of the zinc finger, two equivalents of NEM or IAA in respect to cysteine 
residues and 2 equivalents of EDTA in respect to Co(II)-ion were added.  
 
In the case of NEM the result in Fig. 12 was expected due to the known ability of NEM to 
displace metal-ions from ZFs (Chertova et al., 1998; Morcock et al., 2005). However, 
whether the efficiency of NEM as a hantavirus-inactivating agent lies in its ability to 
 Results and discussion  
73 
 
destroy ZFs still remains elusive since this reagent was also shown to react with Gc and N 
proteins. In addition, possible L protein-reactivity of NEM could not be excluded in these 
experiments. It is also unclear whether NEM can actually react with hantavirus ZF in its 
biological context inside the virion. Furthermore, the possibility that NEM reacts with 
free thiols that are hidden from the more bulky B-mal, IAA or DTNB on the surface of 
the virion (in Gn or Gc) cannot be ruled out. Nevertheless, if it is assumed that ZF is 
required for hantavirus infectivity, it is interesting to speculate about its mode of action. 
There is a single report showing that immunodepletion of arenavirus RING finger-
harboring Z protein from infected cells blocks RNA synthesis (Kolakofsky & Hacker, 
1991). This contradicts the role of Z protein in inhibition of RNA synthesis but suggests 
that the role of the matrix protein in the case of arenaviral RNA synthesis is more diverse 
than expected. The fact that ZF-reactive chemicals abolish arenavirus infectivity certainly 
supports a role for the RING finger in a post-entry RNA synthesis initiation step. Since 
hantaviruses are also inactivated with ZF-reactive chemicals, it is possible that the ZF of 
NSRV possess a more conserved role e.g. in the initiation of viral RNA synthesis. 
Another possibility is that intact ZF of arenaviruses or hantaviruses is required for the 
fusion event of the virus in endosomal membranes. Intact hantavirus ZF was also 
suggested to be required for N protein binding (Wang et al., 2010). However, in the 
immunoprecipitation experiments of native and NEM-inactivated virions with 
glycoprotein-specific mAbs, the interaction between glycoproteins and RNP in response 
to NEM was preserved (III, Fig. 4). This result showed that hantavirus inactivation by 
NEM is not caused by disruption of this interaction. In conclusion, while the possible role 
of the ZF in hantavirus infectivity remains elusive, these results clearly indicate that free 
thiols are necessary for hantavirus infectivity. 
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5 Concluding remarks  
 
This thesis project can be divided into three sub-projects: Hantavirus-induced apoptosis, 
hantavirus packaging and hantavirus entry. In addition, attempts were made to identify 
functions for the Gn zinc finger in hantavirus entry and assembly.  
Hantaviruses do not generally cause apoptosis in cell cultures. Therefore, it was a bit of a 
surprise when it was demonstrated that TULV causes apoptosis in Vero E6 cell line in 
which the virus is propagated (Li et al., 2004). One of the aims of this thesis was to study 
the regulation of cellular signaling pathways in response to TULV infection in order to 
elucidate the mechanisms of TULV-induced apoptosis. Results showed that ERK1/2, 
which belongs to a ubiquitous cell survival pathway, was down-regulated prior to 
induction of apoptosis in TULV-infected cells. Also a coincidental down-regulation of a 
cell surface protein EGFR, which functions upstream of ERK1/2, was observed. Since 
EGFR is known to form a complex with integrins, the cellular receptors of hantaviruses, it 
was hypothesized that apoptosis is linked to regulation of integrins and malfunctioning 
adhesion properties of the infected cells. In our laboratory, apoptosis was previously 
observed only in the case of TULV infection but in this study it was also shown that other 
hantaviruses can cause apoptosis, albeit at a low level. We also determined that the level 
of induced apoptosis is probably related to different growth properties of the individual 
viruses. For unknown reasons TULV seemed to grow faster and to higher titers than other 
hantaviruses studied. In these studies a particular strain of TULV called Moravia was 
used. However, there are other strains of TULV that do not induce apoptosis as readily as 
the Moravia strain (Dr. Alex Plyusnin, personal communication), which suggests that 
these strains have differences in their growth properties. It is probable that the special 
growth properties of TULV Moravia, as revealed in these studies, are obtained by 
spontaneous mutation and is not an inherent difference between hantavirus species. 
Finally, the biological significance of the hantavirus-induced apoptosis could relate to 
kidney dysfunction and proteinuria, which are associated with HFRS. Hopefully, future 
studies will address this question and possibly demonstrate a direct link between 
hantavirus-induced apoptosis and pathogenesis. The mechanistic understanding of 
TULV-induced apoptosis could potentially provide means to combat HFRS.  
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For viral RNPs to be efficiently packaged into progeny virions during hantavirus budding, 
it has been proposed that RNPs need to interact with the envelope glycoproteins. This is 
thought to be achieved by a direct interaction between N protein and cytoplasmic tail of 
Gn. Initial studies suggested that this hypothesis may, indeed, be correct (Koistinen and 
Li et al., personal communication). However, while the initial studies were conducted 
solely by recombinant proteins, in the present study it was shown that there is interaction 
between native Gn and N protein in purified virions. In addition, it was observed that Gn-
CT also interacted with nucleic acids, thereby suggesting that the recognition of RNP by 
Gn-CT is not entirely mediated by protein-protein interactions. These results showed that 
the Gn-CT of hantaviruses is a surrogate matrix protein, which, in the case of other 
NSRVs, have functions outside its role in acting as a link between the viral envelope and 
the virus core. One such function is the regulation of viral RNA synthesis. Thus, it may 
be hypothesized that this could also be the case in hantaviruses where Gn-CT might 
interfere with RNA synthesis, perhaps through its nucleic-acid binding activity. The 
initial hypothesis was that the Gn-CT could interact with RNP through its ZF domain but 
in contradictory to this assumption the mapping results revealed binding sites on both 
sides adjacent to ZF fold. Therefore, as suggested by Wang et al. (2010), an intact ZF is 
likely to play a regulatory role in the recognition of the RNP but probably cannot directly 
bind N protein. In addition, the C-terminal part of Gn-CT was found to have the strongest 
affinity towards RNP, N protein and nucleic acids. This domain includes a putative 
endocytosis motif YxxL, which has been suggested to be important for Gn-CT interaction 
with N protein (Koistinen and Li, personal communication). The interactions that are 
described in this study are probably fundamental to hantavirus assembly and are, 
therefore, a suitable target for antivirals. The mapping data of these interactions revealed 
possible peptide targets which could be used as lead compounds in the development of 
chemicals that inhibit virus assembly and thus infectivity. 
The third sub-project of this thesis focused on possible role of hantaviral ZF in virus 
entry. This was because in the case of retro- and arenaviruses thiol-blocking compounds 
can block virus infectivity by destroying the ZF-fold of these viruses. Therefore, the 
possible virus-inactivating effects of this type of compounds were tested also for 
hantaviruses. Indeed, it was found that a thiol-alkylating compound, NEM, blocked 
hantavirus infectivity. This reagent was able to react with multiple proteins of the virus 
and unfortunately the observed loss of infectivity could not be pin-pointed to the 
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destruction of the ZF fold. Further studies are still needed to fully elucidate the actual 
mechanism of how NEM can inactivate hantaviruses and whether it involves the 
functions of the ZF. Nevertheless, it was also determined that the inactivated hantavirus 
retained its surface structure and functions of its glycoproteins. This suggested that NEM-
inactivated hantaviruses could provoke effective neutralizing antibody responses in 
individuals and could, therefore, be considered as candidates for vaccine development. 
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